
- HOME
- ÇлçÁ¤º¸
- ´ëÇпø°úÁ¤
´ëÇпø°úÁ¤
- 1¼ö°½Åû Àü¿ë URL (http://sugang.korea.ac.kr:7080/graduate) Á¢¼ÓÇÑ´Ù.
- 2ÀçÇлýÀº ¿¬±¸Áöµµ (DKK500, 2ÇÐÁ¡)¸¦ 4ÇбⰣ 8ÇÐÁ¡À» À̼ö
- 3Á¹¾÷¿¡ ÇÊ¿äÇÑ ÃëµæÇÐÁ¡Àº ¼®»ç 24ÇÐÁ¡, ¹Ú»ç 36ÇÐÁ¡, ¼®.¹Ú»çÅëÇÕ 54ÇÐÁ¡
- 4ÀÇ(ÇØºÎ»ý¸®°è,º´¸®»çȸ°è,³»°ú°è,¿Ü°ú°è)
- ¼®»ç°úÁ¤ : ±âÃʰøÅë 9ÇÐÁ¡, Àü°øÇʼö 6ÇÐÁ¡ÀÌ»ó, Àü°ø¼±Åà 9ÇÐÁ¡ÀÌ»ó
- ¹Ú»ç°úÁ¤ : ±âÃʰøÅë 9ÇÐÁ¡, ÀÇÇаøÅë¼¼¹Ì³ª 3ÇÐÁ¡, Àü°øÇʼö 12ÇÐÁ¡ÀÌ»ó, Àü°ø¼±Åà 12ÇÐÁ¡ÀÌ»ó
- 5ÀÇ(ÀÇ»ý¹°°úÇаè)
- ¼®»ç°úÁ¤ : ±âÃʰøÅë 6ÇÐÁ¡, Àü°øÇʼö°ú¸ñ 6ÇÐÁ¡ ÀÌ»ó, µ¿Àϰè Àü°ø¼±Åðú¸ñ 6ÇÐÁ¡ ÀÌ»ó, ÀÇ »ý¹°°úÇÐ°è°øÅë¼¼¹Ì³ª 6ÇÐÁ¡
- ¹Ú»ç°úÁ¤ : ±âÃʰøÅë 9ÇÐÁ¡, ÀÇÇаøÅë¼¼¹Ì³ª 3ÇÐÁ¡, Àü°øÇʼö 12ÇÐÁ¡ÀÌ»ó, Àü°ø¼±Åà 12ÇÐÁ¡ÀÌ»ó
- ¼ö°´ë»ó : ³í¹®¹ßÇ¥¼¼¹Ì³ª 4ÇбâÁß ÇÑÇбâ´Â ÇʼöÀûÀ¸·Î ½Åû ÇÏ¿©¾ßÇÔ
- ¼®.¹Ú»çÅëÇÕ°úÁ¤ : ±âÃʰøÅë°ú¸ñ 9ÇÐÁ¡, Àü°øÇʼö°ú¸ñ 18ÇÐÁ¡ ÀÌ»ó, ÀÇ»ý¹°°úÇÐ°è °øÅë¼¼¹Ì³ª 9ÇÐÁ¡, ³í¹®¹ßÇ¥¼¼¹Ì³ª 3ÇÐÁ¡ ¹× µ¿Àϰè Àü°ø¼±Åðú¸ñ 15ÇÐÁ¡ ÀÌ»ó, °è 54ÇÐÁ¡ ÀÌ»óÀ» À̼ö
- 6º¸°ÇÇÐÇùµ¿°úÁ¤
- ¼®»ç°úÁ¤Àº ±âÃʰøÅë°ú¸ñ 9ÇÐÁ¡ ÀÌ»ó(±âÃÊ Çʼö °ú¸ñ Æ÷ÇÔ), Àü°ø°ú¸ñ 9ÇÐÁ¡ ÀÌ»ó(Àü°ø Çʼö °ú¸ñ Æ÷ÇÔ)À¸·Î °è 27ÇÐÁ¡ ÀÌ»óÀ» ¹Ýµå½Ã À̼öÇÏ¿©¾ß Çϸç, ¹Ú»ç°úÁ¤Àº ±âÃʰøÅë 6ÇÐÁ¡ ÀÌ»ó À» Æ÷ÇÔÇÏ¿© ÃÑ 36ÇÐÁ¡ ÀÌ»óÀ» ¹Ýµå½Ã À̼ö
- 7ÀÇÇÐÅë°èÇÐÇùµ¿°úÁ¤
- ¼®»ç°úÁ¤ ÇлýÀº ÀÇÇÐÅë°èÇÐ ÀÌ·Ð 1, ÀÇÇÐÅë°èÇÐ ÀÌ·Ð 2, ÀÇÇÐÅë°è »ó´ã 1, ¿ªÇÐ(ÃÑ 4°ú¸ñ 12ÇÐÁ¡)À» Çʼö°ú¸ñÀ¸·Î ¹Ýµå½Ã À̼ö
- 8ÀǰúÇаú
- ¼®»ç°úÁ¤ : ±âÃʰøÅë 6ÇÐÁ¡, Àü°øÇʼö 6ÇÐÁ¡ ÀÌ»ó, ÀϹݼ±Åà 6ÇÐÁ¡ ÀÌ»ó ¹× ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª 6ÇÐÁ¡
- ¹Ú»ç°úÁ¤ : ±âÃʰøÅë 12ÇÐÁ¡, Àü°øÇʼö 9ÇÐÁ¡, ÀϹݼ±Åà 9ÇÐÁ¡ ÀÌ»ó, ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª 9ÇÐÁ¡, ÀǰúÇÐ ¿¬±¸ À±¸® 3ÇÐÁ¡ ¹× ÀϹݼ±Åà 15ÇÐÁ¡ ÀÌ»ó
- ¼®.¹Ú»çÅëÇÕ°úÁ¤ : ±âÃʰøÅë 12ÇÐÁ¡, Àü°øÇʼö 15ÇÐÁ¡ ÀÌ»ó, ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª 9ÇÐÁ¡, ÀǰúÇÐ ¿¬±¸ À±¸® 3ÇÐÁ¡ ¹× ÀϹݼ±Åà 15ÇÐÁ¡ ÀÌ»ó
- ÀÇ»ý¹°°úÇаè/ÀǰúÇаú ȨÆäÀÌÁö URL (http://kumcbk21.korea.ac.kr/)
Çлç¾È³»
-
1Áöµµ±³¼ö ½Åû
- ¼®¡¤¹Ú»ç°úÁ¤¿¡ ÀÔÇÐÇÑ ½ÅÀÔ»ýÀº ¹Ýµå½Ã "Áöµµ±³¼ö ½Åû¼"¸¦ ÀÛ¼ºÇÏ¿© ÇбâÃÊ 20ÀÏ À̳»¿¡ Á¦Ãâ
- ÀýÂ÷ :'Áöµµ±³¼ö ½Åû¼(¼Ò¼Ó´ëÇÐ ÇлçÁö¿øºÎ ºñÄ¡)'¿¡ Áöµµ±³¼ö È®ÀÎÀ» ¹Þ¾Æ ÇлçÁö¿øºÎ¿¡ Á¦Ãâ
-
2ÇÐÁ¡ÀÎÁ¤
ÃʰúÇÐÁ¡ : º» ´ëÇпø ¼®»çÇÐÀ§°úÁ¤½Ã ÃʰúÃëµæÇÑ ÇÐÁ¡À» ¹Ú»çÇÐÀ§°úÁ¤¿¡¼ ÀÎÁ¤¹Þ´Â °Í À» ¸»Çϸç ÃÖ°í 6ÇÐÁ¡±îÁö ÀÎÁ¤- ÀýÂ÷ : 'ÇÐÁ¡ÀÎÁ¤½Åû¼'¸¦ ÀÛ¼ºÇÏ°í ¼®»çÇÐÀ§°úÁ¤ ¼ºÀûÇ¥¸¦ ÷ºÎÇÏ¿© Áöµµ±³¼ö ¹× ÇаúÁÖÀÓÀÇ È®ÀÎÀ» °ÅÃÄ ÇбâÃÊ 20ÀÏÀ̳»¿¡ Á¦Ãâ
- È®ÀÎ : ÇØ´ç Çб⸻¿¡ ¼ºÀû ¿¶÷
- 3¿Ü±¹¾î½ÃÇè
- µî·Ï ù ÇбâºÎÅÍ ÀÀ½Ã °¡´É(¹Ú»ç, ¼®»ç: ¿µ¾î, ¿Ü±¹ ±¹Àû ¼ÒÁöÀÚ : Çѱ¹¾î)
- ±¹Á¦¾îÇпø
- 4Á¾ÇÕ½ÃÇè
- ´ë»ó : ¹Ú»ç[3Çб⠵î·Ï 27ÇÐÁ¡ ÀÌ»ó], ¼®»ç[2Çб⠵î·Ï 18ÇÐÁ¡ ÀÌ»ó]
- ½ÃÇè½Ã±â : 4¿ùÃÊ, 10¿ùÃÊ
- 5¿¬±¸°èȹ¼ Á¦Ãâ
- ´ë»ó : ¹Ú»ç°úÁ¤ 4Çб⿡ Á¦Ãâ(2012³â Àü±â ÀÔÇÐÀÚºÎÅÍ´Â ¹Ú»ç°úÁ¤ 2ÇбâºÎÅÍ Á¦Ãâ °¡´É)
- Á¦Ãâ½Ã±â : 3¿ùÃÊ, 9¿ùÃÊ
- 6ÇÐÀ§Ã»±¸³í¹® °ø°³ ¹ßÇ¥
- ¿¬±¸°èȹ¼ ½É»ç¸¦ Åë°úÇÑ Àڷμ ÇÐÀ§Ã»±¸³í¹® Á¦Ãâ ´ë»óÀÚ
- Á¦Ãâ½Ã±â : 2¿ù¸», 8¿ù¸»
- 7ÇÐÀ§Ã»±¸³í¹® Á¦Ãâ
- ³í¹®Á¦Ã⿬ÇÑ : ÀÔÇг⵵·ÎºÎÅÍ ¹Ú»ç 10³â, ¼®»ç´Â 6³â °æ°úÇÑ ÈÄ¿¡´Â Á¦ÃâÇÒ ¼ö ¾øÀ½
- Á¦Ãâ½Ã±â : 4¿ù¸», 10¿ù¸»
Á¦30Á¶(Áöµµ±³¼ö À§ÃË)
¨ç ÀÔÇаú µ¿½Ã¿¡ ¼Ò¼Ó´ëÇÐÀåÀº ÇлýÀÇ Àǻ縦 ÂüÀÛÇÏ¿© ´ÙÀ½ °¢ È£ÀÇ ±âÁØÀ» ÃæÁ·ÇÏ´Â ±³¿øÀ» Áöµµ±³¼ö·Î À§ÃËÇÑ´Ù. (2010Çг⵵ Àü±â ÀÔÇÐÀÚºÎÅÍ Àû¿ë) Áöµµ±³¼ö À§ÃËÀÏ ÀÌÀü 3³â°£ SCI±Þ ±¹Á¦Àú¸íÇмúÁö¿¡ 1ÆíÀÌ»ó ³í¹®À» ÁÖÀúÀÚ ¶Ç´Â ±³½ÅÀúÀÚ·Î °ÔÀçÇÑ º»±³ ±³¿ø
Á¦54Á¶(¹Ú»çÇÐÀ§ û±¸³í¹® Á¦ÃâÀÚ°Ý)
¨ç (2009Çг⵵ Èıâ ÀÔÇÐÀÚºÎÅÍ Àû¿ë ) SCI±Þ ±¹Á¦Àú¸íÇмúÁö¿¡ 1Æí ÀÌ»óÀÇ ³í¹®À» ÁÖÀúÀÚ ¶Ç´Â ±³½ÅÀúÀÚ·Î °ÔÀçÇÑ ÀÚ.
Á¦ 28Á¶ (Áöµµ±³¼ö ÁöÁ¤°ú¸ñ)
¨ç ¼®»ç ¶Ç´Â ¹Ú»ç°úÁ¤ ÀÔÇÐÀÚ´Â ÀÔÇÐÈÄ Ã¹ÇбâÃÊ¿¡ Áöµµ±³¼ö¿Í ¸é´ãÇÏ¿© Áöµµ±³¼ö ÁöÁ¤°ú¸ñÀ» Á¤ÇÑ´Ù. (2010Çг⵵ Àü±â ÀÔÇÐÀÚºÎÅÍ Àû¿ë)
"Áöµµ±³¼ö ÁöÁ¤°ú¸ñ¡°À̶õ ÇÐÀ§¿¡ ÇÊ¿äÇÑ ±³°úÇÐÁ¡ ¿Ü¿¡ Ãß°¡·Î À̼öÇÏ¿©¾ß ÇÒ Àǹ«ÇÐÁ¡À¸·Î Áöµµ±³¼öÀÇ ÆÇ´Ü¿¡ µû¶ó ÁöÁ¤ ¶Ç´Â ¸éÁ¦ÀÇ ÁöÁ¤¼¸¦ ÀÛ¼ºÇÏ¿© Á¦ÃâÇÑ´Ù ÀÇÇаú´Â ¸éÁ¦ ½Åû¼¸¦ Á¦ÃâÇÑ´Ù(´Ü, ÀÇ»ý¹°°úÇаè¿Í Çùµ¿°úÁ¤Àº ÁöÁ¤ ¶Ç´Â ¸éÁ¦ ½Åû¼¸¦ Á¦ÃâÇÑ´Ù.)
ÀÇÇаú °³¼³°ú¸ñ
| ±¸ºÐ | °ú¸ñÄÚµå | ±³°ú¸ñ¸í | ÇÐÁ¡ | ||
|---|---|---|---|---|---|
| ±âÃʰøÅë°ú¸ñ | MED 507 | ½ÇÇèÇüÅÂÇÐ(Experimental Morphology) | 3 | ||
| MED 502 | ½ÇÇè»ý¸®ÇÐ(Practical Physiology) | 3 | |||
| MED 503 | ½ÇÇè»ýÈÇÐ(Practical Biochemistry) | 3 | |||
| MED 504 | ½ÇÇè¾à¸®ÇÐ(Experimental Pharmacology) | 3 | |||
| MED 505 | ¿°Áõ-¸é¿ªº´¸®(Pathology of inflammation and immunity) | 3 | |||
| MED 506 | Á¾¾çº´¸®ÇÐ(Pathology of Neoplasia) | 3 | |||
| MED 509 | ÀÓ»ó±â»ýÃæÇÐ(Clinical Parasitology) | 3 | |||
| MED 510 | ÀÓ»ó¹ýÀÇÇÐ(Clinical Jurisprudence) | 3 | |||
| MED 512 | ÀÇÀ±¸®ÇÐ(Medical Ethics) | 3 | |||
| MED 513 | º´¿ø°ü¸®ÇÐ(Hospital Management) | 3 | |||
| MED 514 | ÀÇÇб³À°·Ð(Study on Medical Education) | 3 | |||
| MED 515 | ³»°ú°èÅäÇÈ(Topics in Internal Medicine Field) | 3 | |||
| MED 516 | ¿Ü°ú°èÅäÇÈ(Topics in Surgery Field) | 3 | |||
| MED 517 | ÀÇÇÐÁ¤º¸Ã³¸®·Ð(Medical Information Processing) | 3 | |||
| MED 518 | ÀÇÇаøÅë¼¼¹Ì³ª(Medical Seminar) | 3 | |||
| MED 520 | ±Ù°ÅÁß½ÉÀÇÇÐ(Evidence Based Medicine) | 3 | |||
| MED 536 | ÀÇÇÐÅë°èÇÐ(Medical Statistics) | 3 | |||
| MED 537 | ÀÇÇבּ¸ ¹æ¹ý·Ð(Medical Research Methodology) | 3 | |||
| MED 539 | ¿ªÇа³·Ð(Introduction to Epidemiology) | 3 | |||
| MED 540 | ÀÇ·áÁ¤º¸ÇÐ(Medical Informatics) | 3 | |||
| MED 547 | ÇǺα¹¼ÒÁÖ»ç¿ä¹ý(Mesotherapy) | 3 | |||
| MED 548 | Á¾¾çÀÇ ºÐÀÚ¼¼Æ÷»ý¹°ÇÐ ÀÔ¹® (Introduction to molecular and cellular biology of tumors) |
3 | |||
| MED 549 | ȯ°æº´¸®ÇÐ(Environmental pathology) | 3 | |||
| MED 550 | ÀÇÇб³À°Çа³·Ð( Introduction to Medical Education) | 3 | |||
| MED 551 | ÀÇ·á Ä¿¹Â´ÏÄÉÀ̼Ç( Medical Communication Skills) | 3 | |||
| MED 552 | ÃֽŠÀÇ·áÁ¤º¸ÇÐ( Contemporary Medical Informatics ) | 3 | |||
| MED 553 | ÀÇ·áÀι®ÇÐ ÀÔ¹®( Introduction to Medical Humanities ) | 3 | |||
| MED 555 | ÀÇÇÐ³í¹®ÀÛ¼º (Biomedical Writing) | 3 | |||
| Àü°ø°ú¸ñ | ÇØºÎ»ý¸®°è | ÇØºÎÇÐ | MED 601 | ±â°ü¹ß»ýÇÐ(Organogenesis) | 3 |
| MED 605 | ÀÇÇÐÀ¯ÀüÇÐ(Medical Genetics) | 3 | |||
| MED 610 | ü¼¼Æ÷À¯ÀüÇÐ(Somatic Cell Genetics) | 3 | |||
| MED 611 | ºÐÀڽŰæ»ý¹°ÇÐ(Molecular Neurobiology) | 3 | |||
| MED 622 | ¹ß´Þ½Å°æÇغÎÇÐ(Developmental Neuroanatomy) | 3 | |||
| MED 623 | ¿µ»óÇØºÎÇÐ(Anatomical Image Analysis) | 3 | |||
| MED 624 | ÀÇÇнÇÇ赿¹°ÇÐ(Medical Laboratory Animal) | 3 | |||
| MED 659 | °í±Þ½Å°æÇغÎÇÐ(Advanced Neuroanatomy) | 3 | |||
| MED 909 | ½Å°æÁٱ⼼Æ÷·Ð(Neural stem cell biology) | 3 | |||
| MED 933 | ½Å°æ³»ºÐºñÇÐ(Neuroendocrinology) | 3 | |||
| MED 1122 | ÀÇ¿ëÇö¹Ì°æÇÐ(Medical Microscopy) | 3 | |||
| MED 1123 | ¸ö (The Body) | 3 | |||
| MED 1124 | ¼¼Æ÷½ÅÈ£Àü´Þ (Cell Signal Transduction) | 3 | |||
| MED 1183 | °í±ÞºÐÀÚ¼¼Æ÷»ý¹°ÇÐ(Molecular and Cellular Biology | 3 | |||
| »ý¸®ÇÐ | MED 613 | »ýü¸·ÀÇ ¹°Áú¿î¹Ý(Membrane Transport) | 3 | ||
| MED 614 | ½Ã³À½ºÀü´Þ(Synaptic Transmission) | 3 | |||
| MED 615 | ¿îµ¿°èÀÇ »ý¸®(Physiology of Motor System) | 3 | |||
| MED 616 | °¨°¢°èÀÇ »ý¸®(Physiology of Sensory System) | 3 | |||
| MED 617 | ½Å¼¼´¢°üÀÇ »ý¸®(Physiology of Renal Tubule) | 3 | |||
| MED 618 | ±ÙÀ°ÀÇ »ý¸®(Muscle Physiology) | 3 | |||
| MED 619 | È£ÈíÀÇ »ý¸®(Respiratory Physiology) | 3 | |||
| MED 620 | ¼øÈ¯ÀÇ »ý¸®(Physiology of Circulation) | 3 | |||
| »ýÈÇÐ | MED 625 | È¿¼ÒÇÐ(Enzymology) | 3 | ||
| MED 626 | ´Ü¹éÁúÇÕ¼º(Protein Synthesis) | 3 | |||
| MED 627 | À¯ÀüÀÚ¹ßÇöÀÇ Á¶Àý(Regulation of Gene Expression) | 3 | |||
| MED 628 | Áß°£´ë»ç(Intermediary Metabolism) | 3 | |||
| MED 629 | ºñŸ¹ÎÇÐ(Vitaminology) | 3 | |||
| MED 630 | ¾Æ¹Ì³ë»ê´ë»ç(Metabolism of Amino Acids) | 3 | |||
| MED 631 | ´ë»çÁ¶Àý(Regulation of Metabolic Processes) | 3 | |||
| MED 632 | ´ë»çÈ£¸£¸óÇÐ(Metabolic Endocrinology) | 3 | |||
| MED 633 | Á¾¾çÈÇÐ(Biochemistry of Oncology) | 3 | |||
| MED 634 | ¸é¿ªÈÇÐ(Immunochemistry) | 3 | |||
| MED 635 | °í±Þ¿µÇâÇÐ(Nutritional science) | 3 | |||
| MED 636 | À¯ÀüÀÚÁ¶ÇÕ±â¼ú(Recombinant DNA Technology) | 3 | |||
| MED 1100 | ºÐÀÚÀÇÇÐÀÇ Ãֽŵ¿Çâ(Current Topics in Molecular Medicine) | 3 | |||
| MED 1125 | ½ÅÈ£Àü´Þ»ýÈÇÐ (Biochemistry of Cell Signaling) | 3 | |||
| MED 1126 | ·ÎÈÀÇ »ý¹°ÇÐ (Biochemical Aspects of Aging) | 3 | |||
| ¾à¸®ÇÐ | MED 637 | ÀÓ»ó¾à¸®ÇÐ(Clinical Pharmacology) | 3 | ||
| MED 644 | µ¶¼ºÇÐ(Toxicology) | 3 | |||
| MED 671 | ½ÅÈ£Àü´Þ ¾à¸®ÇÐ(Signal Transduction Pharmacology) | 3 | |||
| MED 1185 | ÀÚÀ²½Å°æ°è ¾à¸®ÇÐ(Autonomic Nervous System Pharmacology) | ||||
| MED 1186 | ºÐÀڽŰæ¾à¸®ÇÐ (Molecular Neuropharmacology) | 3 | |||
| MED 1187 | À¯ÀüÀÚ Ä¡·áÇÐ (Gene-based Therapy) | 3 | |||
| MED 1188 | ¸é¿ª¹×¿°Áõ¾à¸®ÇÐ(Immune and Inflammatory Pharmacology) | ||||
| MED 1190 | ¿¡³ÊÁö-Ç×»ó¼ºÁ¶Àý ¾à¸®ÇÐ(Energy-Homeostasis Pharmacology) | ||||
| º´¸®»çȸ°è | º´¸®ÇÐ | MED 647 | ¿Ü°úº´¸®ÇÐ(Surgical pathology) | 3 | |
| MED 648 | ºÐÀÚº´¸®ÇÐ(Molecular pathology) | 3 | |||
| MED 649 | ¹Ì¼¼±¸Á¶º´¸®ÇÐ(Ultrastructural pathology) | 3 | |||
| MED 650 | ¼¼Æ÷º´¸®ÇÐ (Cytopathology) | 3 | |||
| MED 651 | »ý½Ä±âº´¸®ÇÐ (Pathology of reproductive system) | 3 | |||
| MED 652 | ¼Òȱ⺴¸®ÇÐ (Gastrointestinal pathology) | 3 | |||
| MED 653 | ½ÉÆóº´¸®ÇÐ (Cardiopulmonary pathology) | 3 | |||
| MED 654 | °£º´¸®ÇÐ(Hepatopathology) | 3 | |||
| MED 655 | ½ÅÀ庴¸®ÇÐ(Renal pathology) | 3 | |||
| MED 656 | °ñ°Ý°èº´¸®ÇÐ(Musculoskeletal patholoogy) | 3 | |||
| MED 657 | ½Å°æº´¸®ÇÐ(Neuropathology) | 3 | |||
| MED 658 | Á¶Ç÷±âº´¸®ÇÐ(Hematopathology) | 3 | |||
| MED 1127 | ³»ºÐºñº´¸®ÇÐ(Endocrine pathology) | 3 | |||
| MED 1128 | Æó ¹× Á¾°Ýµ¿º´¸®ÇÐ(Pathology of Lung and mediastinum) | 3 | |||
| MED 1129 | µÎ°æºÎ º´¸®ÇÐ(Pathology of head and neck) | 3 | |||
| MED 1130 | ¾Èº´¸®ÇÐ(ophthalmic pathology) | 3 | |||
| MED 1131 | ¿¬ºÎÁ¶Á÷º´¸®ÇÐ(Pathology of soft tissue) | 3 | |||
| ¹Ì»ý¹°ÇÐ | MED 661 | Áø´Ü¹Ì»ý¹°ÇÐ(Clinical and Diagnostic Microbiology) | 3 | ||
| MED 662 | ºÐÀÚ¹ÙÀÌ·¯½ºÇÐ(Molecular Virology) | 3 | |||
| MED 663 | ¹ÙÀÌ·¯½ºÇÐ(Virology) | 3 | |||
| MED 664 | Àü¿°º´ÇÐ(Infectious Disease) | 3 | |||
| MED 665 | ¹Ì»ý¹°À¯ÀüÇÐ(Microbial Genetics) | 3 | |||
| MED 666 | ¼¼±Õ´ë»çÇÐ(Microbial Metabolism) | 3 | |||
| MED 667 | Á¶Á÷¹è¾ç(Tissue Culture) | 3 | |||
| MED 670 | ÀÇÇйÙÀÌ·¯½ºÇÐ(Medical Virology) | 3 | |||
| MED 685 | ÀÇÇÐÁø±ÕÇÐ(Medical mycology) | 3 | |||
| MED 736 | ¼¼±Õº´ÀηÐ(Bacterial pathogenesis) | 3 | |||
| MED 862 | ¹Ì»ý¹°¿ªÇÐ(Microbial epidemiology) | 3 | |||
| MED 865 | ¹ÙÀÌ·¯½ºº´ÀηÐ(Viral pathogenesis) | 3 | |||
| ¿¹¹æ ÀÇÇÐ |
MED 680 | º¸°ÇÁ¤Ã¥·Ð(Health Policy) | 3 | ||
| MED 697 | Áö¿ª»çȸÀÇÇÐ(Community Medicine) | 3 | |||
| MED 698 | »ê¾÷ÀÇÇÐ(Industrial Medicine) | 3 | |||
| MED 699 | ¸ðÀÚº¸°ÇÇÐ(Maternal Child Health) | 3 | |||
| MED 700 | ¸¸¼ºº´¿ªÇÐ(Epidemiology of Chronic Disease) | 3 | |||
| MED 701 | º¸°ÇÀÇ·áÁ¶Á÷°ú °ü¸®(Health Care Organization and Management) | 3 | |||
| MED 702 | ȯ°æ°ü¸®ÇÐ(Advanced Environmental Health) | 3 | |||
| MED 703 | »ê¾÷Áßµ¶ÇÐ(Industrial Toxicology) | 3 | |||
| MED 705 | ±¹¹ÎÀÇ·á(Medical Care) | 3 | |||
| MED 876 | ȯ°æ°ú °Ç°(Environment and Health) | 3 | |||
| MED 906 | ±¹°¡»ê¾÷º¸°ÇÁ¦µµ ¹× °ü¸®(Occupational health policy & management) | 3 | |||
| ±â»ýÃæÇÐ | MED 673 | ±â»ýÃæÇа³·Ð(Introduction to Parasitology) | 3 | ||
| MED 674 | ±â»ý¼º¿øÃæÇÐ(Parasitic Protozoology) | 3 | |||
| MED 675 | ÀÎü¿¬ÃæÇÐ(Human Helminthology) | 3 | |||
| MED 676 | ÀÇ¿ë°ïÃæÇÐ(Medical Entomology) | 3 | |||
| MED 677 | ±â»ýÃæ¸é¿ªÇÐ(Parasite Immunology) | 3 | |||
| MED 678 | ±â»ýÃæº´Å»ý¹°ÇÐ(Pathobiology of Parasite) | 3 | |||
| ¹ýÀÇÇÐ | MED 682 | ¹ýÀǰ¨½ÄÇÐ(Forensic Criminalistics) | 3 | ||
| MED 683 | ¹ý°úÇаú À¯ÀüÀÚ°Ë»ç(DNA Typing in Forensic Medicine) | 3 | |||
| MED 686 | ¹ýÀǵ¶¹°ÇÐ(Forensic Toxicology) | 3 | |||
| MED 687 | ¹ýÀǰ˽ÃÇÐ(Medicolegal Investigation) | 3 | |||
| MED 688 | ÀÇ·á¹ýÇÐ(Law and Medicine) | 3 | |||
| MED 689 | ¹ýÀǺ´¸®ÇÐ(Forensic Pathology) | 3 | |||
| MED 1121 | ¹ýÀǰïÃæÇÐ(Forensic Entomology) | 3 | |||
| ÀÇÇÐ ±³À°ÇÐ |
MED 1243 | ±³À°°úÁ¤°³¹ß ( Curriculum Development ) | 3 | ||
| MED 1244 | ±³À°¿¬±¸¹æ¹ý·Ð-°í±Þ ( Methods in Educational Research-Advanced ) | 3 | |||
| MED 1245 | ±³À°Æò°¡ ÀÔ¹® ( Introduction to Educational Evaluation ) | 3 | |||
| MED 1246 | °í±ÞÅë°è¸¦ ÀÌ¿ëÇÑ ±³À°½É¸®ÃøÁ¤ÇÐ ( Educational Measurement and Psychometrics using advanced statistics ) |
3 | |||
| MED 1247 | ¼ºÀα³¼öÇнÀÀÌ·Ð ( Teaching and Learning in Adult ) | 3 | |||
| MED 1248 | ±³¼ö°³¹ß ( Faculty Development ) | 3 | |||
| MED 1249 | ½Ã¹Ä·¹À̼ÇÀ» ÀÌ¿ëÇÑ ÀÇÇб³À° ( Simulation in Medical Education ) | 3 | |||
| MED 1250 | ÀÇÇÐÀü¹®¼º ¿¬±¸ ( Research in Medical Professionalism ) | 3 | |||
| MED 1251 | ÀÇÇб³À° ½Ç¹« ¿¬±¸ ( Medical Education Field Research ) | 3 | |||
| MED 1252 | ÀÇÇÐöÇÐ ( Medical philosophy ) | 3 | |||
| MED 1253 | ±³À°¿¬±¸¹æ¹ý·Ð-±âÃÊ ( Methods in Educational Research-Basic ) | 3 | |||
| MED 1254 | ÀÇÇб³À°¿¡¼ÀÇ ¸®´õ½Ê ( Leadership in Medical Education ) | 3 | |||
| MED 1256 | ÀÓ»ó»óȲ¿¡¼ÀÇ ±³À° ( Clinical Teaching ) | 3 | |||
| ÅëÇÕ ÀÇÇÐ |
MED 1175 | ÅëÇÕÀÇÇÐ ( Integrative Medicine ) | 3 | ||
| MED 1178 | ½É½ÅÀÇÇÐ ( Mind Body Medicine | 3 | |||
| MED 1179 | ÀÚ¿¬ÀÇÇÐ ( Naturopathic Medicine ) | 3 | |||
| MED 1180 | ½ºÆ®·¹½º °ü¸® ( Stress management ) | 3 | |||
| MED 1181 | °Ç°±â´É½Äǰ ( Functional Food ) | 3 | |||
| MED 1182 | ¹®Á¦ÇذáÁ᫐ ÅëÇÕÀÇÇÐ ( Problem Based Learning Integrative Medicine) | 3 | |||
| ³»°ú°è | ³»°úÇÐ | MED 691 | ½ÅºÎÀüÀÇ º´ÀηÐ(Pathophysiology of Renal failure) | 3 | |
| MED 692 | ½Å´ëÄ¡·á¹ý(Renal replacement therapy) | 3 | |||
| MED 708 | Æó¼øÈ¯(Pulmonary Circulation) | 3 | |||
| MED 709 | ½ÇÇè½ÅÀåÇÐ(Experimental Nephrology) | 3 | |||
| MED 710 | ½ÅÀ庴ÇÐ(Renal Diseases) | 3 | |||
| MED 711 | ÀÚ°¡¸é¿ª¼º³»ºÐºñÁúȯ(Autoimmune Endocrine Diseases) | 3 | |||
| MED 712 | È£¸£¸ó°ú ¼ö¿ëü(Hormone and Receptor) | 3 | |||
| MED 713 | °¨¿°º´ÀÇ º´ÀηÐ(Pathogenesis of Infectious Diseases) | 3 | |||
| MED 714 | Ç×»ýÁ¦·Ð(Antibiotics) | 3 | |||
| MED 715 | ½ÉÀåÇ÷°ü°èº´Å»ý¸®(Pathophysiology of Cardiovascular Disease) | 3 | |||
| MED 716 | ½ÉÀå¾à¸®ÇÐ(Cardiac Pharmacology) | 3 | |||
| MED 717 | ºÎÁ¤¸ÆÇÐ(Arrhythmology) | 3 | |||
| MED 719 | È£Èí±âº´Å»ý¸®ÇÐ(Respiratory Pathophysiology) | 3 | |||
| MED 720 | Æó¼â¼ºÆóÁúȯ(Obstructive Lung Diseases) | 3 | |||
| MED 721 | ÀåÈí¼ö»ý¸®ÇÐ(Intestinal Transport) | 3 | |||
| MED 722 | À§Àå°üÀÇ ³»ºÐºñÇÐ(Gastrointestinal Hormone) | 3 | |||
| MED 723 | °£Á¾¾ç·Ð(Liver Oncology) | 3 | |||
| MED 724 | °£ÀÇ´ë»çÁúȯ(Metabolic Diseases of Liver) | 3 | |||
| MED 725 | °£¿°ÇÐ(Hepatitis Virology) | 3 | |||
| MED 726 | ¸¸¼º°£Áúȯ(Chronic Liver Disease) | 3 | |||
| MED 727 | ¼ÒȰüÁ¾¾ç(Neoplasm of Digestive Tract) | 3 | |||
| MED 728 | ¼Òȼº±Ë¾ç·Ð(Peptic Ulcer) | 3 | |||
| MED 729 | ¹ß¾Ï±âÀü(Mechanism of Carcinogenesis) | 3 | |||
| MED 730 | Á¾¾çÀÇ ³»°úÀû Ä¡·áÀÇ ¿ø¸®(Principles of Cancer Chemotherapy) | 3 | |||
| MED 731 | ¼÷ÁÖÀǹæ¾î±âÀü(Host Defence Mechanism) | 3 | |||
| MED 732 | ±Þ¼ºÃéÀå¿°°³·Ð(Acute Pancreatitis) | 3 | |||
| MED 734 | ´ã³¶ ¹×´ãµµ¾Ï°³·Ð(Cancer of Biliary Tract) | 3 | |||
| MED 735 | È£Èí±â¸é¿ªÇÐ(Respiratory Immunology) | 3 | |||
| MED 737 | ¿°Áõ¼º ÀåÁúȯ·Ð(Inflammatory Bowel Disease) | 3 | |||
| MED 738 | Ç÷¾×Çа³·Ð(Hematology) | 3 | |||
| MED 739 | ¼Òȱâ¿îµ¿ÇÐ(Gastrointestinal Motility | 3 | |||
| MED 741 | µ¿¸Æ°æÈÀÇ º´Å»ý¸®(Pathophysiologic Mechanisms of Atherogenesis) | 3 | |||
| MED 743 | °ñ¼öÀ̽ķÐ(Bone Marrow Transplantation) | 3 | |||
| MED 744 | 1Çü ´ç´¢º´ÀÇ ¸é¿ªº´ÀηÐ(Immunopathogenesis of Type I Diabetes Mellitus) | 3 | |||
| MED 745 | Àν¶¸°ºñÀÇÁ¸¼º °´¢º´ÀÇ º´ÀηÐ(Pathogenesis of Noninsulin Dependent Diabetesellius) | 3 | |||
| MED 746 | ÀÚ°¡¸é¿ª¼º °©»ó¼±Áúȯ(Autoimmune Thyroid Disease) | 3 | |||
| MED 747 | ±â°üÁöõ½Ä(Bronchial Asthma) | 3 | |||
| MED 813 | Àü½ÅÀû ·ù¸¶Æ¼½ºÁúȯ¿¡ ´ëÇÑ À¯Àüü¿¬±¸(Genome Research for Systemic Rheumatic Disease) | 3 | |||
| MED 863 | ½É±Ùº´ÇÐ(Myocardial Disease) | 3 | |||
| MED 892 | °ü»óÇ÷·ù¿ªÇÐ(Coronary Hemodynamics) | 3 | |||
| MED 907 | ·ù¸¶Æ¼½º °üÀý¿°ÀÇ º´ÀηÐ(Pathogenesis of Rheumatoid Arthritis) | 3 | |||
| MED 908 | Àü½ÅÀû ÀÚ°¡¸é¿ªÁúȯÀÇ ¸é¿ªÄ¡·á¿ä¹ý(Immunomodulation of Systemic Autoimmune Disease) | 3 | |||
| MED 947 | °£Áú¼º ÆóÁúȯ(Interstitial Lung Diseases) | 3 | |||
| MED 975 | °áÇÙÇÐ(Tuberculosis Studies) | 3 | |||
| MED 1155 | ½ÉÀå ºÎÁ¤¸ÆÇÐ (Cardiac electrophysiology) | 3 | |||
| ¼Ò¾Æ û¼Ò³â °úÇÐ |
MED 748 | Å»ýÀ¯ÀüÇÐ(Embryo Genetics) | 3 | ||
| MED 749 | ¼Ò¾Æ°¨¿°ÇÐ(Infectious Diseases in Pediatrics) | 3 | |||
| MED 750 | ¼Ò¾ÆÇ÷¾×ÇÐ(Pediatric Hemeatology) | 3 | |||
MED 751 |
½Å»ý¾ÆÇÐ(Neonatology) | 3 | |||
| MED 752 | ¼Ò¾Æ½ÉÀåÇÐ(Pediatric Cardiology) | 3 | |||
| MED 753 | ¼Ò¾Æ½ÅÀåÇÐ(Pediatric Nephrology) | 3 | |||
| MED 754 | ¼Ò¾Æ¿µ¾çÇÐ(Nutrition in Pediatrics) | 3 | |||
| MED 755 | ¼Ò¾Æ³»ºÐºñÇÐ ¹× ´ë»çÀå¾Ö(Pediatric Endocrinology £¦ Metabolic Diseases) | 3 | |||
| MED 756 | û¼Ò³âÀÇÇÐ(Adolescent Medicine) | 3 | |||
| MED 757 | ¼Ò¾ÆÁ¾¾çÇÐ(Pediatric Oncology) | 3 | |||
| MED 758 | ¼Ò¾Æ½Å°æÇÐ(Pediatric Neurology) | 3 | |||
| MED 759 | ¼Ò¾Æ ¾Ë·¹¸£±âÇÐ(Pediatric Allergy) | 3 | |||
| ÇǺΠ°úÇÐ |
MED 784 | ÇǺμö¼úÇÐ(Skin Surgery) | 3 | ||
| MED 785 | ÇǺÎÁø±ÕÇÐ(Mycology of the Skin) | 3 | |||
| MED 786 | ÇǺθ鿪ÇÐ(Immunology of the Skin) | 3 | |||
| MED 787 | ÇǺκ´¸®Á¶Á÷ÇÐ(Histopathology of the Skin) | 3 | |||
| MED 790 | ·ÎÀÎÇǺκ´ÇÐ(Geriatric Dermatology) | 3 | |||
| MED 864 | ¸ð¹ßÁúȯ ¿¬±¸(Hair Diseases) | 3 | |||
| MED 920 | ÀÓ»ó ·¹ÀÌÀú ÀÇÇÐ(Clinical Laser Therapy) | 3 | |||
| MED 921 | ÇǺÎÁúȯ°ú µðÁöÅÐ ¿µ»ó(Skin Diseases and Digital Image) | 3 | |||
| MED 981 | °Ç¼±(Psoriasis) | 3 | |||
| MED 995 | ¿©µå¸§(Acne) | 3 | |||
| MED 996 | ¾ÆÅäÇÇ ÇǺο°(Atopic disease) | 3 | |||
| MED 997 | ±¤ÀÇÇÐ(Photomedicine) | 3 | |||
| MED 998 | ÇǺÎÀ庮(Skin Barrier) | 3 | |||
| MED 999 | ÈÀåǰ ¹× ÇǺι̿ëÇÐ(Cosmetics) | 3 | |||
| MED 1079 | »ö¼Ò ÀÌ»óÁõ(Pigment Anomaly) | 3 | |||
| MED 1191 | ¿ø°Ý ÇǺΰúÇÐ (Teledermatology) | 3 | |||
| MED 1192 | ÇǺΠ»ýü°øÇÐ (Bioengineering of the skin) | 3 | |||
| MED 1193 | ¾àÁø (Drug eruption) | 3 | |||
| MED 1194 | ÇǺΠÁ¾¾çÇÐ (Skin Tumors) | 3 | |||
| ½Å°æ °úÇÐ |
MED 684 | ÀÓ»óÀü±â»ý¸®ÇÐ(Clinical Electrophysiology) | 3 | ||
| MED 693 | ¸»ÃʽŰ溴Áõ¹×±ÙÀ°º´(Peripheral neuropathy and Myopathy) | 3 | |||
| MED 762 | Àü±â»ý¸®ÇÐ(Erectro Physiology) | 3 | |||
| MED 763 | Áø´Ü½Å°æÇÐ(Diagnostic Neurology) | 3 | |||
| MED 764 | ½Å°æ³»ºÐºñÇÐ(Neuroendocrinology) | 3 | |||
| MED 765 | ÀÓ»ó½Å°æÇÐ(Clinical Neurology) | 3 | |||
| MED 766 | ½Å°æ»ý¹°ÇÐ(Neurobiology) | 3 | |||
| MED 767 | ¼Ò¾Æ½Å°æÇÐ(Child Neurology) | 3 | |||
| MED 768 | ¿îµ¿Àå¾Ö(Movement Disorder) | 3 | |||
| MED 769 | ½Å°æ°úÇÐ(Neuroscience) | 3 | |||
| MED 770 | °£ÁúÇÐ(Epileptology) | 3 | |||
| MED 984 | ³úÁ¹Áß(Stroke) | 3 | |||
| MED 1097 | ½Å°æ º¯¼ºÁúȯ ¹× Ä¡¸Å(Neurodegenerative disorders and dementias) | 3 | |||
| MED 1098 | ô¼ö Áúȯ(spinal cord disorders) | 3 | |||
| MED 1260 | ÀÓ»ó³ëÀνŰæÇÐ | 3 | |||
| Á¤½Å °úÇÐ |
MED 774 | »ý¹°Á¤½ÅÀÇÇÐ(Biological Psychiatry) | 3 | ||
| MED 775 | ½Å°æÁ¤½Å°úÇÐ(Neuropsychiatry) | 3 | |||
| MED 776 | Á¤½ÅÄ¡·á(Psychotherapy) | 3 | |||
| MED 777 | Á¤½Å¾à¹°ÇÐ(Psychopharmacology) | 3 | |||
| MED 778 | ¼Ò¾Æ ¹× û¼Ò³âÁ¤½ÅÀÇÇÐ(Child and Adolescent Psychiatry) | 3 | |||
| MED 779 | Áö¿ª»çȸÁ¤½ÅÀÇÇÐ(Community Psychiatry) | 3 | |||
| MED 780 | ·ÎÀÎÁ¤½ÅÀÇÇÐ(Geriatric Psychiatry) | 3 | |||
| MED 932 | Çൿ°úÇÐ(Behavioral Science) | 3 | |||
| MED 1080 | ÀÚ¹®Á¶Á¤ Á¤½ÅÀÇÇÐ(Consultation-Liaison Psychiatry) | 3 | |||
| ¿µ»ó ÀÇÇÐ |
MED 1132 | ½Å°æÁßÀçÄ¡·áÀÇÇÐ(Interventional Neuroradiology) | 3 | ||
| MED 1133 | ¿µ»óÀÇÇпø¸®(Essentials of Imaging Diagnosis) | 3 | |||
| MED 1134 | ¼Ò¾Æ¿µ»óÀÇÇÐ(Pediatric Radiology) | 3 | |||
| MED 1135 | ÈäºÎ¿µ»óÀÇÇÐ(Thoracic Radiology) | 3 | |||
| MED 1136 | ½Å°æ¿µ»óÀÇÇÐ(Neuroradiology) | 3 | |||
| MED 1137 | µÎ°æºÎ¿µ»óÀÇÇÐ(Head and Neck Radiology) | 3 | |||
| MED 1196 | ½ÉÀåÇ÷°ü¿µ»óÀÇÇÐ(Cardiovascular Radiology) | 3 | |||
| MED 1139 | º¹ºÎ¿µ»óÀÇÇÐ(Abdominal Radiology) | 3 | |||
| MED 1140 | ºñ´¢»ý½Ä±â¿µ»óÀÇÇÐ(Urogenital Radiology) | 3 | |||
| MED 1141 | ±Ù°ñ°Ý¿µ»óÀÇÇÐ(Musculoskeletal Radiology) | 3 | |||
| MED 1142 | ÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐ(Interventional Radiology) | 3 | |||
| MED 1143 | À¯¹æ¿µ»óÀÇÇÐ(Breast Radiology) | 3 | |||
| ¹æ»ç¼± Á¾¾çÇÐ |
MED 695 | ¹æ»ç¼±Á¾¾çÇÐÀÇ ¿ø¸®(Principles of Radiation Oncology) | 3 | ||
| MED 696 | ¹æ»ç¼± »ý¹°ÇÐ(Radiation Biology) | 3 | |||
| MED 706 | ¹æ»ç¼±¿µ»ó¹ýÀÇ ¿ø¸®(Principles of Radiological Imaging) | 3 | |||
| MED 707 | ¹æ»ç¼±¹°¸®ÇÐÀÇ ¿ø¸®(Principles of Radiation Physics) | 3 | |||
| MED 740 | ¼±·®ÃøÁ¤¹ý(Radiation Dosimetry) | 3 | |||
| MED 760 | »ý¹°ÀÇÇבּ¸¿¡¼ÀÇ µ¿À§¿ø¼ÒÇÐ(Radionuclides in Biomedical Research) | 3 | |||
| MED 761 | ¹æ»ç¼±Ä¡·á¹ý Ư°(Special Topics in Radiation Treatment) | 3 | |||
| MED 805 | µÎ°æºÎÁ¾¾ç(Head and Neck Cancer) | 3 | |||
| MED 838 | ÈäºÎÁ¾¾ç(Thoracic Cancer) | 3 | |||
| MED 931 | ºñ´¢±â°è Á¾¾ç(Genitourinary Cancer) | 3 | |||
| MED 946 | ºÎÀΰú Á¾¾ç(Gynecologic Cancer) | 3 | |||
| MED 972 | ¼ÒȱâÁ¾¾ç(Gastrointestinal Tract Cancer) | 3 | |||
| Áø´Ü°Ë»ç ÀÇÇÐ |
MED 809 | Ç÷¾×º´¸®(Hematopathology) | 3 | ||
| MED 810 | ÀÓ»ó¹Ì»ý¹°ÇÐ(Diagnostic Microbiology) | 3 | |||
| MED 811 | Á¾¾ç»ý¹°ÇÐ(Tumor biology) | 3 | |||
| MED 812 | °Ë»çÁ¤º¸Ã³¸®¹æ¹ý·Ð(Laboratory Information and Management System) | 3 | |||
| MED 814 | ¼öÇ÷ÀÇÇÐ(Transfusion Medicine) | 3 | |||
| MED 815 | ÀÎü¹æ¾î±âÀü·Ð(Defensive Mechanism) | 3 | |||
| MED 816 | Ç÷¾×ÀÀ°í¿Í Ç÷Àü(Hemostasis and thrombosis) | 3 | |||
| MED 817 | Á¤µµ°ü¸®Åë°è(Quality Control And Statistics) | 3 | |||
| MED 818 | ¼¼Æ÷À¯ÀüÇÐ(Cytogenetics) | 3 | |||
| MED 819 | Áø´Ü¸é¿ªÇ÷ûÇÐ(Diagnostic seroimmunology) | 3 | |||
| °¡Á¤ ÀÇÇÐ |
MED 820 | °¡Á¤ÀÇÇп¡¼ÀÇ ³ë³âȯÀÚ°ü¸®(The Geriatric Care in Family Medicine) | 3 | ||
| MED 821 | ÀÇÇÐ³í¹®°³·Ð(Interpreting the Medical Literature in Family Medicine) | 3 | |||
| MED 822 | °¡Á¤ÀÇÇÐ ¼¼¹Ì³ª(The Seminar in Family Medicine) | 3 | |||
| MED 823 | ÀÓ»ó ÀÏÂ÷Áø·á³»°¡Á··Ð(The Family in Medical Practice-A Family System Primer) | 3 | |||
| MED 827 | âÁ¶Àû ÀÇÇб³À°·Ð(Creative Medical Teaching) | 3 | |||
| MED 828 | Çѱ¹ÀdzëÀκ´(Disease of Korean Elderly in the Gerontological Aspects) | 3 | |||
| MED 829 | ³ëÀκ´·Ð(Geriatrics) | 3 | |||
| MED 839 | ³ëÀο¡¼ÀÇ °Ç°ÁõÁø(Health Promotion in the Elderly) | 3 | |||
| MED 851 | ¸»±â ȯÀÚÀÇ ÅëÁõ ¹× Áõ»ó °ü¸®(Pain and Symptom Control in Terminal Patients) | 3 | |||
| MED 852 | ¿ÏÈÀÇ·á À±¸®(Palliative Care Ethics) | 3 | |||
| MED 1081 | Áúº´¿¹¹æ°ú °Ç°ÁõÁø(Disease Prevention and Health Promotion) | 3 | |||
| MED 1082 | ÀÓ»óÀÇ·áÁ¤º¸·Ð(Clinical informatics) | 3 | |||
| MED 1083 | ¿©ÇàÀÇÇÐ(Travel Medicine) | 3 | |||
| MED 1103 | ÀÇ·á ÀÇ»ç¼ÒÅë(Health communication) | 3 | |||
| MED 1261 | ÀÓ»óºñ¸¸ÇÐ | 3 | |||
| MED 1262 | ´ë»çÁõÈıºÀÇ º´ÀηР| 3 | |||
| ÇÙÀÇÇÐ | MED 1144 | ÇÙÀÇÇй°¸®ÇÐ ±âÃÊ (Fundamentals of Nuclear Medicine Physics) | 3 | ||
| MED 1145 | ½Å°æÇÙÀÇÇÐ (Nuclear Neurology) | 3 | |||
| MED 1146 | ÇÙÀÇÇпµ»óºÐ¼®ÇÐ (Nuclear Medicine Image Analysis) | 3 | |||
| MED 1147 | ½ÉÀåÇÙÀÇÇÐ (Nuclear Cardiology) | 3 | |||
| MED 1148 | ¼Òȱâ°èÇÙÀÇÇÐ (Gastrointestinal nuclear medicine) | 3 | |||
| MED 1149 | ºñ´¢±â°èÇÙÀÇÇÐ (Urologic Nuclear Medicine) | 3 | |||
| MED 1150 | ¾çÀüÀÚ¹æÃâ´ÜÃþÃÔ¿µÀÇ ÀÌÇØ (Advance Image Analysis using PET) | 3 | |||
| MED 1151 | ¹æ»ç¼ºÀǾàǰÀÇ ±âÃÊ (Basics of Radiopharmaceuticals) | 3 | |||
| MED 1152 | µ¿À§¿ø¼ÒÄ¡·áÇÐ (Radiosiotope Therapy) | 3 | |||
| MED 1153 | ±Ù°ñ°Ý°èÇÙÀÇÇÐ (Musculoskeletal Nuclear Medicine) | 3 | |||
| MED 1154 | ºÐÀÚ¿µ»óÀÇÇÐ (Molecular Imaging) | 3 | |||
| MED 1157 | ÇÙÀÇÇÐ ¿µ»ó ¿ø¸® (Principles of Nuclear Medicine Imaging) | 3 | |||
| ¿Ü°úÇÐ | MED 830 | °©»ó¼±Áúȯ(Thyroid Disease) | 3 | ||
| MED 831 | ³»ºÐºñ°èÁ¾¾ç(Endocrine Tumor) | 3 | |||
| MED 832 | À¯¹æ¾Ï(Breast Cancer) | 3 | |||
| MED 833 | À§¾Ï(Gastric Cancer) | 3 | |||
| MED 834 | °£¾Ï(Hepatoma) | 3 | |||
| MED 835 | ´ãµµ¾Ï(Biliary Duct Cancer) | 3 | |||
| MED 836 | ´ëÀåÁ÷Àå¾Ï(Colorectal Cancer) | 3 | |||
| MED 837 | ´ã¼®Áõ(Biliary Stone) | 3 | |||
| Á¤Çü ¿Ü°úÇÐ |
MED 840 | Á¤Çü¿Ü°ú»ýµ¿·ÂÇÐ(Orthopedic Biomechanics) | 3 | ||
| MED 841 | ¿Ü»óÇÐ(Traumatology) | 3 | |||
| MED 842 | Á¤Çü¿Ü°úÀû ÀÀ¿ëÇØºÎÇÐ(Orthopedic Applied Anatomy) | 3 | |||
| MED 843 | Á¤Çü¿Ü°úº´¸®ÇÐ(Orthopedic Pathology) | 3 | |||
| MED 844 | Á¤Çü¿Ü°ú¼ö¼úÇÐ(Orthopedic Operative Surgery) | 3 | |||
| MED 845 | °üÀý¼ºÇü¼ö¼úÇÐ(Arthroplasty) | 3 | |||
| MED 846 | ¼öºÎÀç°Ç ¹× ¹Ì¼¼¼ö¼úÇÐ(Microsurgery) | 3 | |||
| MED 847 | ¼Ò¾ÆÁ¤Çü¿Ü°úÇÐ(Pediatric Orthopedics) | 3 | |||
| MED 848 | ¸²»ó½ºÆ÷Ã÷ÀÇÇÐ(Sports Medicine) | 3 | |||
| MED 849 | ¼ºÀθ¸¼º°üÀýº´ÇÐ(Chronic Arthritis) | 3 | |||
| MED 1084 | °ñ¿¬ºÎÁ¶Á÷À̽ÄÇÐ(Bone and Soft tissue Transplantation) | 3 | |||
| ½Å°æ ¿Ü°úÇÐ |
MED 854 | ½Å°æ ÇØºÎÇÐ(Neuroanatomy) | 3 | ||
| MED 855 | ½Å°æ Áø´ÜÇÐ(Neurodiagnosis) | 3 | |||
| MED 856 | ½Å°æÇа³·Ð(Neurology) | 3 | |||
| MED 857 | ½Å°æ ¼ö¼úÇÐ(Operating Neurosurgery) | 3 | |||
| MED 858 | ½Å°æ ¹æ»ç¼±ÇÐ(Neuro-Radiology) | 3 | |||
| MED 859 | ½Å°æ°è Á¾¾çÇÐ(Neuro-Oncology) | 3 | |||
| MED 860 | ½Å°æ°è ¿Ü»óÇÐ(Neurotraumatology) | 3 | |||
| MED 861 | ¼Ò¾Æ ½Å°æ¿Ü°úÇÐ(Pediatric Neurosurgery) | 3 | |||
| ÈäºÎ ¿Ü°úÇÐ |
MED 866 | È£Èí±â¿Ü°úÇÐ(Respiratory Surgery) | 3 | ||
| MED 867 | ±â°ü ¹× ½Äµµ¿Ü°úÇÐ(Tracheo-Esophageal Surgery) | 3 | |||
| MED 868 | ÈäºÎÁ¾¾çÇÐ(Thoracic Oncology) | 3 | |||
| MED 869 | Ç÷°ü¿Ü°úÇÐ(Vascular Surgery) | 3 | |||
| MED 870 | Ç÷·ÂÇÐ(Hemodynamics) | 3 | |||
| MED 871 | ¼±Ãµ¼º½ÉÀå¿Ü°úÇÐ(Congenital Cardiac Surgery) | 3 | |||
| MED 872 | ÈÄõ¼º½ÉÀå¿Ü°úÇÐ(Acquired Cardiac Surgery) | 3 | |||
| MED 873 | °üµ¿¸Æ¿Ü°úÇÐ(Coronary Surgery) | 3 | |||
| MED 874 | ½ÉÀåÀ̽ĿܰúÇÐ(Cardiac Transplantation Surgery) | 3 | |||
| MED 875 | ¿Ü°úÀû ½ÉÆó»ý¸®(Cardio Pulmonary Surgical Pathology) | 3 | |||
| MED 1085 | ¸»±â½ÉÀ庴¿Ü°úÇÐ(Surgical Managements for Endstage Heart Disease) | 3 | |||
| MED 1198 | Àΰø½ÉÀåÇÐ(Artificial Heart) | 3 | |||
| ¼ºÇü ¿Ü°úÇÐ |
MED 881 | µÎ°æºÎ¿Ü°úÇÐ(Head and Neck Surgery) | 3 | ||
| MED 884 | ¹Ì¼¼Ç÷°üÇÐ(Microvascular Surgery) | 3 | |||
| MED 886 | ¼öºÎÀç°ÇÇÐ(Hand Reconstructive Surgery) | 3 | |||
| MED 887 | À¯¹æ¼ºÇüÇÐ(Breast Plastic Surgery) | 3 | |||
| MED 888 | ¾Ç¾È¸éÀç°ÇÇÐ(Maxillofacial Reconstructive Surgery) | 3 | |||
| MED 889 | ¾È¼ºÇüÇÐ(Opthalmic Plastic Surgery) | 3 | |||
| MED 1087 | ¸ð¹ß¼ºÇüÇÐ(Hair Restoration Surgery) | 3 | |||
| MED 1088 | Áö¹æ¼ºÇüÇÐ(Lipo-Plastic Surgery) | 3 | |||
| MED 1200 | ¿Ü»óÇÐ(Traumatology) | 3 | |||
| MED 1202 | ¼¼Æ÷ ¹× Á¶Á÷À̽ÄÇÐ(Cell and Tissue Transplantation Surgery) | 3 | |||
| MED 1203 | ¾È¸é±âÇüÀç°ÇÇÐ(Reconstructive Surgery for Congenital Head and Neck Anomaly) | 3 | |||
| MED 1204 | »çÁö ü°£ºÎ Àç°ÇÇÐ(Reconstructive Surgery for Body and Extremity Anomaly) | 3 | |||
| MED 1205 | ÀϹݹ̿뼺ÇüÇÐ1(General Aesthetic Plastic Surgery-1) | 3 | |||
| MED 1206 | ÀϹݹ̿뼺ÇüÇÐ2(General Aesthetic Plastic Surgery-2) | 3 | |||
| MED 1207 | ¾Ç¾È¸é¹Ì¿ëÇÐ (Maxillofacial Aesthetic Surgery) | ||||
| MED 1209 | ºñ¼ºÇüÇÐ(Plastic Surgery for Nose) | 3 | |||
| »êºÎÀÎ °úÇÐ |
MED 895 | ºÎÀΰú³»ºÐºñÇÐ(Gynecologic Endocrinology) | 3 | ||
| MED 896 | »ê°ú³»ºÐºñÇÐ(Endocrinology in Obstetrics) | 3 | |||
| MED 898 | ÁÖ»ê±âÇÐ(Perinatology) | 3 | |||
| MED 902 | »êºÎÀΰú¼¼Æ÷À¯ÀüÇÐ(Cytogenetics in Obstetrics & Gynecology) | 3 | |||
| MED 1156 | ºÒÀÓÇÐ (Infertility) | 3 | |||
| MED 1158 | Àڱ󻸷Áõ (Endometriosis) | 3 | |||
| MED 1159 | Æó°æ±âÇÐ (Menopause) | 3 | |||
| MED 1160 | ºÎÀΰúÁ¾¾çÇÐ 1(Gynecologic Oncology 1- Cervical cancer, vulva cancer) | 3 | |||
| MED 1161 | »êºÎ·É¿ªÀÇ ÃÊÀ½ÆÄÇÐ((Ultrasound in Obstetrics) | 3 | |||
| MED 1162 | ºÎÀΰúÁ¾¾çÇÐ 2(Gynecologic Oncology 2- Preinvasive cervical lesions) | 3 | |||
| MED 1163 | ºÎÀΰúÁ¾¾çÇÐ 3(Gynecologic Oncology 3- Ovarian malignancy) | 3 | |||
| MED 1164 | ºÎÀΰúÁ¾¾çÇÐ 5(Gynecologic Oncology 5- Gestational trophoblastic disease) | 3 | |||
| MED 1165 | ºÎÀΰúÁ¾¾çÇÐ 4(Gynecologic Oncology 4- Endometrial cancer) | 3 | |||
| MED 1167 | ¼Ò¾Æ.»çÃá±â ºÎÀΰúÇÐ (Pediatric Adolescent Gynecology) | 3 | |||
| ºñ´¢±â °úÇÐ |
MED 910 | ºñ´¢»ý½Ä±âÁø´ÜÇÐ(Diagnosis on Genitourinary Tract) | 3 | ||
| MED 911 | ºñ´¢±â¼ö¼úÇÐ(Urologtic Surgery) | 3 | |||
| MED 912 | ºñ´¢»ý½Ä±âÁ¾¾çÇÐ(Genitourinary Tract Oncology I) | 3 | |||
| MED 913 | ½Å°æ ¹× ³à¼ººñ´¢±â°úÇÐ(Neurology and Female Urology) | 3 | |||
| MED 914 | ³²¼ººÒÀÓÇÐ(Male Infertility) | 3 | |||
| MED 915 | ³²¼º°úÇÐ(Andrology) | 3 | |||
| MED 916 | ³»½Ã°æ¼ö¼úÇÐ(Endoscopic Surgery) | 3 | |||
| MED 917 | ºñ´¢»ý½Ä±âÁ¾¾çÇÐ(Genitourinary Tract Oncology) | 3 | |||
| MED 918 | ¼Ò¾Æºñ´¢±â°úÇÐ(Pediatric Urology) | 3 | |||
| MED 919 | ºñ´¢»ý½Ä±â°¨¿°ÇÐ(Genitourinary Tract Infection) | 3 | |||
| À̺ñÀÎ ÈİúÇÐ |
MED 934 | ÁßÀÌ ¹× ³»ÀÌÇØºÎÇÐ(Fine Structure of Middle and Inner Ear) | 3 | ||
| MED 935 | û°¢ÇÐ ¹× °Ë»ç¹ý(Audiologic Access for Hearing Impairment) | 3 | |||
| MED 936 | À̺ñÀÎÈİúÁ¾¾çÇÐ(Head and Neck Oncology) | 3 | |||
| MED 937 | ÀüÁ¤»ý¸® ¹× °Ë»ç¹ý(Vestibular Physiology and Function Test) | 3 | |||
| MED 938 | Èĵλý¸®ÇÐ(Laryngeal Physiology) | 3 | |||
| MED 939 | ºñ°úº´¸®ÇÐ(Nasal Pathology) | 3 | |||
| MED 940 | ³»ÀÌ»ý¸®ÇÐ(Inner Ear Physiology) | 3 | |||
| MED 941 | ¿Í¿ìÀ̽ÄÇÐ(Cochlear Implants) | 3 | |||
| MED 942 | ºñ¾Ë·¹¸£±âÇÐ(Nasal Allergy) | 3 | |||
| MED 943 | Àελý¸®ÇÐ(Pharyngeal Physiology) | 3 | |||
| MED 944 | À½¼ºÇÐ(Phonetics) | 3 | |||
| MED 945 | µÎ°æºÎÀç°ÇÇÐ(Head and Neck Reconstruction) | 3 | |||
| MED 1257 | ¼ö¸é¹«È£ÈíÁõÀÇ º´Å»ý¸® | 3 | |||
| MED 1258 | Èİ¢ ¹× ¹Ì°¢ »ý¸®ÇÐ | 3 | |||
| MED 1259 | ºñ¿ëÁ¾ÀÇ º´Å»ý¸® | 3 | |||
| ¾È°úÇÐ | MED 922 | ÀϹݾȰú¼ö¼úÇÐ(General Ophthalmic Surgery) | 3 | ||
| MED 923 | ¾È°ú°Ë»ç¹ý ¹× Áø´Ü(General Eye Examination and Its Diagno) | 3 | |||
| MED 924 | ¾È»ý¸®ÇÐ(Ocular Physiology) | 3 | |||
| MED 925 | ¾È±¼ÀýÀÌ»ó ¹× »ý¸®±¤ÇÐ(Refractive Errors and Physiologic Optics) | 3 | |||
| MED 926 | Çü±¤¾ÈÀúÃÔ¿µ¹ý(Fluorescein Angiography) | 3 | |||
| MED 927 | Çö¹Ì°æÇϾȼö¼úÇÐ(Microsurgery of the Eye) | 3 | |||
| MED 928 | ¾È¼ºÇü¼ö¼úÇÐ(Ocular Plastic Surgery) | 3 | |||
| MED 929 | ¾Èº´¸®ÇÐ(Ophthalmic Pathology) | 3 | |||
| MED 930 | ¾È¾à¸®ÇÐ(Ophthalmic Pharmacology) | 3 | |||
| ¸¶Ãë ÅëÁõ ÀÇÇÐ |
MED 960 | ¸¶Ãë°úÇÐ(Anesthesiology) | 3 | ||
| MED 961 | ¼ö¼ú½Ç°ü¸®(Management of Operating Room) | 3 | |||
| MED 962 | µ¿Åë°ü¸®(Management of Pain) | 3 | |||
| MED 963 | È£Èí°ü¸®(Respiratory Care) | 3 | |||
| MED 964 | ÁßȯÀÚ°ü¸®(Critical Care Medicine) | 3 | |||
| MED 965 | »ê°ú¸¶Ãë(Obstetric Anesthesia) | 3 | |||
| MED 966 | ¼Ò¾Æ¸¶Ãë(Pediatric Anesthesia) | 3 | |||
| MED 967 | Àå±âÀ̽ĸ¶Ãë(Anesthesia of Organ Transplantation) | 3 | |||
| MED 968 | ȯÀÚ°¨½Ã(Monitoring of Patient) | 3 | |||
| MED 969 | ½ÉÀ帶Ãë(Cardiac Anesthesia) | 3 | |||
| MED 970 | ³ú½Å°æ¸¶Ãë(Neuroanesthesia) | 3 | |||
| MED 971 | ½ÇÇè ¹× ¿¬±¸(Experiment and Research) | 3 | |||
| Ä¡°úÇÐ | MED 977 | ±¸°.¾Ç¾È¸é ±âÇüÇÐ(Congenital Malformation) | 3 | ||
| MED 978 | ¾Ç¾È¸é º¯ÇüÇÐ(Dentofacial Deformity) | 3 | |||
| MED 982 | ±³Á¤ Áø´ÜÇÐ(Orthodontic Diagnosis) | 3 | |||
| MED 983 | ±³Á¤Ä¡·áÀÇ »ý·ÂÇÐ(Biomechanics in Orthodontics) | 3 | |||
| MED 850 | ±¸°.¾Ç¾È¸é ¿Ü»ó ¹× °¨¿°ÇÐ(Oral and Maxillofacial Trauma and Infection) | 3 | |||
| MED 853 | Ä¡ÁÖº¸Ã¶ÇÐ(Periodontal Prosthodontics) | 3 | |||
| MED 877 | ¾Ç°üÀý Àå¾ÖÇÐ(Temporomandibular Joint Disorder) | 3 | |||
| MED 878 | ¹«Ä¡¾Ç º¸Ã¶ÇÐ(Prosthodontics for Edentulous Patients) | 3 | |||
| MED 879 | ºÎºÐ¹«Ä¡¾Ç º¸Ã¶ÇÐ(Prosthodontics for Partially Edentulous Patients) | 3 | |||
| MED 890 | ±¸°Á¾¾çÇÐ(Oral & Maxillofacial Oncology) | 3 | |||
| MED 891 | º¸Ã¶±³ÇÕ·Ð(Occlusion in Prosthodontics) | 3 | |||
| MED 893 | ±¸°¾Ç¾È¸é ÀÓÇÁ¶õÆ®ÇÐ(Oral & Maxillofacial Implantology) | 3 | |||
| MED 1099 | ÀÓÇÁ¶õÆ®º¸Ã¶ÇÐ(Implant Prosthodontics) | 3 | |||
| ÀçȰ ÀÇÇÐ |
MED 948 | ÀÎü¿îµ¿ÇÐ(Kinesiology) | 3 | ||
| MED 949 | ¹°¸®ÀÇÇÐ(Physical Medicine) | 3 | |||
| MED 950 | ÀçȰÀÇÇÐ(Rehabilitation Medicine) | 3 | |||
| MED 951 | ±ÙÀüµµÇÐ(Electromyography ) | 3 | |||
| MED 952 | ô¼ö¼Õ»óȯÀÚÀÇ ÀçȰ(Rehabilitation of the Spinal Cord Injured) | 3 | |||
| MED 954 | ³ú¼º¸¶ºñÀÇ ÀçȰ(Rehabliltation of Cerebral Palsy) | 3 | |||
| MED 955 | ³úÁ¹ÁßÀÇ ÀçȰ(Rehabilitation of Palsy) | 3 | |||
| MED 956 | ·ù¸ÓƼ½º¼º °üÀý¿°È¯ÀÚÀÇ ÀçȰ(Rehabilitation of the Rheumatoid Arthritis) | 3 | |||
| MED 957 | ±ÙÀ°?°ñ°Ý°è ÁúȯÀÇ ÀçȰ(Rehabilitation of Musculoskeletal Disorders) | 3 | |||
| MED 958 | ½ÉÀåÀçȰ(Cardiac Rehabilitation) | 3 | |||
| MED 959 | ¿îµ¿»ý¸®(Exercise Physiology) | 3 | |||
| MED 742 | ÀÇÁöÇÐ(Prosthesis) | 3 | |||
| MED 781 | º¸Á¶±â(Orthosis) | 3 | |||
| MED 1089 | ÅëÁõÄ¡·á(Management of Pain) | 3 | |||
| ÀÀ±Þ ÀÇÇÐ |
MED 993 | ¼îÅ©(Shock) 1 | 3 | ||
| MED 994 | ¼îÅ©(Shock) 2 | 3 | |||
| MED 1091 | Ư¼ö »óȲ¿¡¼ÀÇ ÀÀ±Þ ÀÇÇÐ(Emergency medicine in Unique environment) | 3 | |||
| MED 1092 | ÀÀ±Þ ȯÀÚÀÇ °¨½Ã ü°è(Surveilance of Emergency patient) | 3 | |||
| MED 1094 | ÀÀ±Þ ÁßȯÀÚ ÀÇÇÐ(Critical care in Emergency medicine ) | 3 | |||
| MED 1119 | ÀçÇØ ÀÇÇÐ(Disaster medicine) | 3 | |||
| MED 1166 | ÀÀ±Þ¼ú±âÇÐ (Emergency procedures) | 3 | |||
| MED 1169 | ¼Ò»ýÀÇÇÐ(¼Ò»ýÀÇÇÐ) (Resuscitation medicine) | 3 | |||
| MED 1210 | µ¶¹°ÇÐ¹× ¾à¹°ÇÐ ( toxico-pharmacology in EM ) | 3 | |||
| MED 1211 | ÀÀ±ÞÀÇ·á ü°è ( Emergency medical service systems ) | 3 | |||
| MED 1212 | ÀÀ±ÞÀÇ·áÀÇ µµ´ö¹× ÀÇ·á ¹ýÀû ¿¬±¸ ( Ethical and legal issues in EM) | 3 | |||
| MED 1213 | Àü¹®Àû ¿Ü»ó óġÇÐ ( Advanced trauma life support ) | 3 | |||
| MED 1214 | ÀÀ±Þ Ç×»ó¼º ¹ÝÀÀ (Homeostasis in acute situations ) | 3 | |||
| MED 1215 | ÀÀ±Þ °¨¿°ÇÐ ( Acute Infectious Disorders in EM) | 3 | |||
| MED 1216 | ±Þ¼º ¼Õ»ó Á¶Àý ¼Ò»ý¼ú (Damage control resuscitation in trauma patient) | 3 | |||
| MED 1217 | ÀÀ±ÞÀÇÇÐ ¿µ¿ª¿¡¼ÀÇ ½ÅÀÇ·á ±â¼ú (New technology in EM) | 3 | |||
| MED 1263 | ¼Õ»ó¿¡¼ÀÇ ¸é¿ªÁ¶Àýü°è | 3 | |||
| MED 1264 | ¿Ü»óȯÀÚÀÇ ¼ö¾×óġ | 3 | |||
BK21ÀÇ»ý¹°°úÇаè ÀÇÇаú ÀÇ»ý¹°°úÇÐ°è °³¼³°ú¸ñ
| ±¸ºÐ | °ú¸ñÄÚµå | ±³°ú¸ñ¸í | ÇÐÁ¡ | |
|---|---|---|---|---|
| ±âÃʰøÅë°ú¸ñ | MED 521 | ÀÎü»ý¸®ÇÐ(Human Physiology) | 3 | |
| MED 522 | ¿¬±¸½ÇÇè±â¹ý(Laboratory Methods) | 3 | ||
| MED 523 | ÀÎÃ¼ÇØºÎÇÐ(Human Anatomy) | 3 | ||
| MED 525 | ¹Ì»ý¹°ÇÐ ¹× ¸é¿ªÇÐ(Microbiology and Immunology) | 3 | ||
| MED 526 | ÀÇ»ý¸í °úÇÐÁ¤º¸(Biomedical Infomatics) | 3 | ||
| MED 527 | ±âÃʺ´¸®ÇÐ °³·Ð(Basic Pathology) | 3 | ||
| MED 528 | ½ÇÇ赿¹°ÇÐ(Experimental Animal) | 3 | ||
| MED 529 | ºÐÀÚ¼¼Æ÷»ý¹°ÇÐ(Molecular and Cell Biology) | 3 | ||
| MED 530 | ÀÓ»óÀÇÇÐ °³·Ð(Introduction to the Clinical Medicine) | 3 | ||
| MED 531 | ÀÇ»ý¹°°úÇÐ°è °øÅë ¼¼¹Ì³ª I(Biomedical Seminars I) | 3 | ||
| MED 532 | ÀÇ»ý¹°°úÇÐ°è °øÅë ¼¼¹Ì³ª II(Biomedical Seminars II) | 3 | ||
| MED 533 | ÀÇ»ý¹°°úÇÐ°è °øÅë ¼¼¹Ì³ª III(Biomedical Seminars III) | 3 | ||
| MED 534 | ÀÇ»ý¹°°úÇÐ°è °øÅë ¼¼¹Ì³ª IV(Biomedical Seminars IV) | 3 | ||
| MED 535 | ³í¹®¹ßÇ¥ ¼¼¹Ì³ª(Work-In Progress Seminar) | 3 | ||
| MED 542 | °í±ÞºÐÀÚ¼¼Æ÷»ý¹°ÇÐ(Advanced Molecular and Cell Biology) | 3 | ||
| MED 544 | °í±Þ¸é¿ªÇÐ(Advanced Immunology) | 3 | ||
| MED 545 | ÀÇ»ý¹°ÇÐ ¿¬±¸ ¹æ¹ý·Ð(Research Methodology for Biomedical Science) | 3 | ||
| MED 556 | ¹ß»ýÇа³·Ð (Principles of Developmental Biology) | 3 | ||
| MED 557 | ÃֽŠÀÇ»ý¸í°úÇÐ (Emerging medical biology) | 3 | ||
| MED 559 | º´Å»ý¸®¿Í ¾à¸®ÇÐ (Pathophysiology and Pharmacology) | 3 | ||
| MEd 561 | ¹ÙÀÌ·¯½ºÇÐ ¿ø·Ð (Principles of Virology) | 3 | ||
| MED 563 | ½Å¾à°³¹ßƯ·Ð (Advanced drug discovery and development) | 3 | ||
| MED 564 | Á¦Á¦ÇÐÆ¯·Ð (Advanced Pharmaceutics) | 3 | ||
| MED 565 | »ýÈÇРƯ·Ð I (Advanced Biochemistry I) | 3 | ||
| MED 566 | »ýÈÇРƯ·Ð II (Advanced Biochemistry II) | 3 | ||
| Àü°ø°ú¸ñ | ½Å°æ |
MED 1001 | ½Å°æ»ý¸®ÇÐ(Neurophysiology) | 3 |
| MED 1003 | ½Å°æ¾à¸®ÇÐ(Neuropharmacology) | 3 | ||
| MED 1004 | ÀÚÀ²½Å°æ°è(Autonomic Nervous System) | 3 | ||
| MED 1005 | ºÐÀÚ¼¼Æ÷½Å°æ»ý¹°ÇÐ(Molecular Neurobiology) | 3 | ||
| MED 1007 | ½Å°æ³»ºÐºñÇÐ(Neuroendocrinology) | 3 | ||
| MED 1008 | ½Å°æ°èÁúȯ(Diseases in the nervous system) | 3 | ||
| MED 1218 | ½Å°æÁ¤½Å¾à¸®ÇÐ (Neuropsychopharmacology) | 3 | ||
| MED 1219 | ³ëÈÀÇ À¯ÀüÇÐ ¸ðµ¨ (Genetic Models in Aging) | 3 | ||
| MED 1220 | Áúº´°ú ÃÊÆÄ¸® À¯ÀüÇÐ (Drosophila Genetics in Human Diseases) | 3 | ||
| MED 1221 | ½Å°æ°úÇÐ ÁÖÁ¦¿¬±¸ (Topics in Neuroscience) | 3 | ||
| MED 1222 | ½Å°æ°úÇÐ ¼¼¹Ì³ª (Seminars in Neuroscience) | 3 | ||
| MED 1223 | ½Å°æ°úÇÐÀÇ ¿ø¸® (Principles of Neural Science) | 3 | ||
ºÐÀÚÀÎü |
MED 1019 | À¯ÀüÀÚÄ¡·áÇÐ °³·Ð(Concepts of Cancer Gene Therapy) | 3 | |
| MED 1020 | »ý¸í°øÇÐÀ±¸®(Ethics of Medical Biotechnology) | 3 | ||
| MED 1071 | °í±Þ ½Å°æ»ý¹°ÇÐ I(Advanced Neurobiology I) | 3 | ||
| MED 1072 | °í±Þ ½Å°æ»ý¹°ÇÐ II(Advanced Neurobiology II) | 3 | ||
| MED 1073 | ¹ß´Þ À¯ÀüÇÐ I(Developmental Genetics I) | 3 | ||
| MED 1074 | ¹ß´Þ À¯ÀüÇÐ II(Developmental Genetics II) | 3 | ||
| MED 1105 | ¼¼Æ÷¸· ¼ö¿ëü¿Í ½ÅÈ£Àü´Þ(Membrane receptors and signal transduction) | 3 | ||
| MED 1106 | ºÐÀÚ ½Å°æ³»ºÐºñÇÐ(Molecular Neuroendocrinology) | 3 | ||
| MED 1109 | Áٱ⼼Æ÷·Ð(Stem Cell Biology) | 3 | ||
| MED 1224 | ºÐÀÚ ¹ß»ý»ý¹°ÇÐ (Molecular Developmental Biology) | 3 | ||
| MED 1225 | Àü»çÀÎÀÚ (transcription factors) | 3 | ||
| MED 1226 | ½ÅÈ£Àü´Þ ºÐÀÚ ³×Æ®¿öÅ© (Molecular networks in signal transduction) | 3 | ||
ÀÇ¿ë»ýü |
MED 1021 | Àǰø ÇǺΰúÇÐ(Dermatology for Bioengineering) | 3 | |
| MED 1022 | »ýü Ç¥¸éÇÐ(Biomedical Metrology) | 3 | ||
| MED 1023 | ÀÇ»ý¸í Çö¹Ì°æÇÐ(Biomedical Microscopy) | 3 | ||
| MED 1024 | °í±Þ ¿µ»ó ºÐ¼®ÇÐ(Advanced Image Analysis) | 3 | ||
| MED 1025 | ¿µ»ó ºÐ¼®ÇÐ ±âÃÊ(Basic Image Analysis) | 3 | ||
| MED 1026 | ¾à¹°Àü´Þü°è(Drug Delivery System) | 3 | ||
| MED 1027 | ÀǰøÇÐ ÁÖÁ¦¿¬±¸ I(Topics in Biomedical Engineering I) | 3 | ||
| MED 1028 | ÀǰøÇÐ ÁÖÁ¦¿¬±¸ II(Topics in Biomedical Engineering II) | 3 | ||
| MED 1030 | ÀΰøÀå±âÇÐ(Artificial Organs) | 3 | ||
| MED 1031 | °íºÐÀÚ »ýüÀç·áÇÐ(Polymers in Biomaterials) | 3 | ||
| MED 1033 | Á¶Á÷ ¹× ¼¼Æ÷°øÇÐ(Tissue and Cellular Engineering) | 3 | ||
| MED 1036 | »ýüÀç·á¿Í »ýüÀûÇÕ¼º(Biomaterials and Biocompatibility) | 3 | ||
| MED 1037 | ³ª³ë »ýüÀç·á(Nano-biomaterials) | 3 | ||
| MED 1038 | ³ª³ë ÀÇ·á±â¼ú Ư·Ð(Topics on Nano-medical Technology) | 3 | ||
| MED 1039 | ÀÇÇй°¸®(Medical Physics) | 3 | ||
| MED 1040 | Àΰø½ÉÀå Æ¯°(Artificial Heart) | 3 | ||
| MED 1077 | ºñħ½ÀÀǰøÇÐ(non-invasive bioengineering) | |||
| MED 1078 | ÈÇпµ»ó Áø´ÜÇÐ(chemical imaging for medical diagnosis) | 3 | ||
| MED 1111 | ÀÇ·á±â±âÇÐ(Technology for the Medical Device) | 3 | ||
| MED 1112 | ¹ÙÀÌ¿À Ĩ °³·Ð(Introduction of Biochip) | |||
| MED 1113 | ºÐÀÚ»ý¹° ÀüÀÚÆ¯·Ð(Biology for Engineers) | |||
°¨¿° |
MED 1041 | °í±ÞºÐÀڹ̻ý¹°ÇÐ(Advanced Molecular Microbiology) | 3 | |
| MED 1042 | ºÐÀÚ¼¼±ÕÇÐ(Molecular Bacteriology) | 3 | ||
| MED 1043 | ÃֽŠÀÇÇйÙÀÌ·¯½ºÇÐ(Emerging Medical Virology) | 3 | ||
| MED 1045 | °í±Þ ¸é¿ªÇÐ I(Advanced Immunology I) | 3 | ||
| MED 1046 | Á¾¾ç¹ÙÀÌ·¯½ºÇÐ(Oncogenic Virology) | 3 | ||
| MED 1048 | °í±Þ ¸é¿ªÇÐ II(Advanced Immunology II) | 3 | ||
| MED 1050 | ¸é¿ªÁúȯ ¿¬±¸(Research of Immune related disease) | 3 | ||
| MED 1227 | °¨¿°Áõ¿¡ ´ëÇÑ ¼±Ãµ¸é¿ª(Innate Immune Response to Infection) | 3 | ||
| MED 1228 | À¯ÀüÀÚ¹é½ÅÀÇ Àü·«(Strategies of Genetic Vaccine) | 3 | ||
| MED 1229 | ÀÏ¹Ý ¸é¿ªÇÐ ¥° (General Immunology) | 3 | ||
| MED 1230 | ÀÏ¹Ý ¸é¿ªÇÐ ¥±(General Immunology) | 3 | ||
| MED 1231 | ½Ã½ºÅÛ»ý¹°ÇÐ (Systems Biology) | 3 | ||
Á¾¾ç |
MED 1051 | Á¾¾ç ºÐÀÚ»ý¹°ÇÐ(Oncogene Molecular Biology) | 3 | |
| MED 1052 | ¾Ï¹ß»ýÇÐ(Carcinogenesis) | 3 | ||
| MED 1053 | ¾ÏÄ¡·áÇÐ(Cancer Treatment) | 3 | ||
| MED 1054 | ¾Ï¿¹¹æÇÐ(Cancer Prevention) | 3 | ||
| MED 1056 | ¼Òȱâ Á¾¾çÇÐ(Gastrointestinal Oncology) | 3 | ||
| MED 1058 | È£Èí±â Á¾¾çÇÐ(Pulmonary Oncology) | 3 | ||
| MED 1116 | ºÐÀÚ»ý¹°ÇРƯ·Ð(Advanced Molecular Biology) | 3 | ||
| MED 1117 | Á¾¾ç ¸é¿ªÇÐ(Tumor Immunology) | 3 | ||
| MED 1118 | ¾Ï ¿ªÇÐ ¹× ¿¹¹æ(Cancer Epidemiology & Prevention) | 3 | ||
| MED 1232 | ÃֽоÏÀ¯ÀüÀÚÇÐ(Emerging Molecular Oncology) | 3 | ||
| MED 1233 | Ç׾ϳ»¼º (Resistance of Tumor Cells to Therapeutics) | 3 | ||
| MED 1234 | Á¾¾çÁٱ⼼Æ÷»ý¹°ÇÐ (Cancer Stem Cell Biology) | 3 | ||
| MED 1235 | Á¾¾ç ºÐÀÚ»ý¹°ÇÐ ¿¬±¸ ±â¹ý | 3 | ||
| MED 1236 | Ç׾ϺÐÀÚÄ¡·á (Anti-tumor Molecular Therapy) | 3 | ||
| MED 1237 | ¾ÏÀüÀÌÀÇ ÀÌÇØ (Understanding of Metastasis) | 3 | ||
| MED 1238 | ¾Ï »ý¹°ÇÐ ÁÖÁ¦¿¬±¸ (Topics in Cancer Biology) | 3 | ||
| MED 1239 | ¾Ï »ý¹°ÇÐ ¼¼¹Ì³ª (Seminars in Cancer Biology) | 3 | ||
ºÐÀÚ¼¼Æ÷
|
MED 1061 | ¼¼Æ÷ÈÇÐ(Cytochemistry) | 3 | |
| MED 1062 | ¹Ì¼¼Á¶Á÷»ý¹°ÇÐ(Ultrastructural Biology of Cell and Tissue) | 3 | ||
| MED 1063 | À¯ÀüÀÚÀÇ ¹ßÇö Á¶Àý(Regulation of Gene Expression) | 3 | ||
| MED 1064 | ³ëÈÀÇ »ý¹°ÇÐ(Biology of Aging) | 3 | ||
| MED 1065 | °í±ÞÀÎü»ýÈÇÐ(Advanced Human Biochemistry) | 3 | ||
| MED 1066 | ¼¼Æ÷ÁÖ±âÁ¶Àý ¹× ¼¼Æ÷»ç¸ê(Cell Cycle and Apoptosis) | 3 | ||
| MED 1068 | »ý¸í°øÇÐ(Biotechnology) | 3 | ||
| MED 1069 | Á¤º¸Àü´Þ°è(Signal Transduction) | 3 | ||
| MED 1070 | Àΰ£ÁúȯÀÇ ±¸Á¶ÇÐÀû Á¢±Ù(Structural Basis of Human Diseases) | 3 | ||
| MED 1240 | ½Å°æ¹ß»ýÀ¯ÀüÇÐ (Neurodevelopmental genetics) | 3 | ||
| MED 1241 | °í±Þ¹ß»ý»ý¹°ÇÐ I (Advanced Developmental Biology I) | 3 | ||
| MED 1242 | °í±Þ¹ß»ý»ý¹°ÇÐ II (Advanced Developmental Biology II) | 3 | ||
º¸°ÇÇÐ Çùµ¿°úÁ¤ °³¼³°ú¸ñ
| ±¸ºÐ | °ú¸ñÄÚµå | ±³°ú¸ñ¸í | ÇÐÁ¡ | ºñ°í |
|---|---|---|---|---|
| ±âÃʰøÅë°ú¸ñ | HLT 501 | º¸°ÇÇÐ °³·Ð(Introduction to Public Health) | 3 | |
| HLT 502 | º¸°Ç Åë°èÇÐ(Biostatistics) | 3 | ||
| HLT 503 | ¿ªÇÐ °³·Ð(Introduction to Epidemiology) | 3 | ¼®»ç Çʼö | |
| HLT 504 | ÀÚ·á 󸮷Ð(Data Processing in Health Research) | 3 | ||
| HLT 505 | º¸°ÇÇÐ ¿¬±¸ ¹æ¹ý·Ð(Methodology for Public Health Research) | 3 | ||
| HLT 506 | º¸°ÇÇÐ ¼¼¹Ì³ª(Seminar in Public Health) | 3 | ||
| HLT 507 | º¸°ÇÅë°èÇÐ I(Biostatictics I) | 3 | ¼®»ç Çʼö | |
| HLT 508 | º¸°ÇÅë°èÇÐ II(Biostatictics II) | 3 | ||
| HLT 509 | º¸°ÇÅë°èÇÐ ½Ç½À(Practice of Biostatistics) | 3 | ||
| HLT 510 | Public Health Issues in the World(¼¼°èÀÇ º¸°Ç¹®Á¦) | 3 | ||
| HLT 511 | º¸°ÇÇРƯ·Ð(Philosophy of Public Health) | 3 | ||
| HLT 512 | º¸°Ç±³À°°ú °Ç°ÁõÁø(Health Education and Promotion) | 3 | ||
| HLT 513 | º¸°ÇÅë°è »ó´ã I(Biostatistical Consulting I) | 3 | ||
| HLT 514 | º¸°ÇÅë°è »ó´ã II(Biostatistical Consulting II) | 3 | ||
| HLT 516 | ³ëÈ¿Í °Ç°(Aging and Health) | 3 | ||
| HLT 518 | º¸°ÇÇÐ ³í¹®ÀÛ¼º¹ý(Writing for Public Health) | 3 | ||
| ȯ°æº¸°Ç°úÇÐ Àü°ø°ú¸ñ | HLT 551 | »ê¾÷ ¹× ȯ°æº¸°ÇÇÐ °³·Ð(Fundamentals of Occupational and Environmental Health) | 3 | |
| HLT 552 | ȯ°æ ¹× »ê¾÷ µ¶¼ºÇÐ °³·Ð(Introduction of Enronmental and Occupational Toxicology) | 3 | ||
| HLT 553 | ¼¼Æ÷ µ¶¼ºÇÐ(Molecular Toxicology) | 3 | ||
| HLT 555 | ÀÛ¾÷ȯ°æÆò°¡(Evaluation of Workplace Environment) | 3 | ||
| HLT 556 | »ê¾÷º¸°Ç°ü¸®(Occupational Health Policy and Management) | 3 | ||
| HLT 557 | »ê¾÷ ¿ªÇÐ(Occupational Epidemiology) | 3 | ||
| HLT 558 | »ê¾÷º¸°Ç ¼¼¹Ì³ª(Seminar in Occupational Health) | 3 | ||
| HLT 559 | Àΰ£°ú ȯ°æ(Human and Environment) | 3 | ||
| HLT 560 | »ýüÁöÇ¥(Biomarkers) | 3 | ||
| HLT 561 | ±â±âºÐ¼® ÀÌ·Ð ¹× ½Ç½À ÃʱÞ(Basic Theory and Practice of Analytical Instruments) | 3 | ||
| HLT 562 | »ê¾÷À§»ý¼¼¹Ì³ª(Seminar in occupational hygiene) | 3 | ||
| HLT 564 | »ýÈÇÐ ¹× ¼¼Æ÷ »ý¹°ÇÐ(Biochemistry and Cell Biology) | 3 | ||
| HLT 565 | »ê¾÷º¸°Ç»ç·Ê ¿¬±¸(Case studies of occupational diseases and accidents) | 3 | ||
| HLT 566 | ±â±âºÐ¼® ÀÌ·Ð ¹× ½Ç½À Áß±Þ(Intermediate Theory and Practice of Analytical Instruments) | 3 | ||
| HLT 567 | ºÐÀÚ»ý¹°ÇÐ ¹× ½Ç½À(Molecular Biology) | 3 | ||
| HLT 568 | ȯ°æº¸°Ç ³í¹®Ãʵ¶ ¼¼¹Ì³ª(Seminar on Environmental health Literature) | 3 | ||
| HLT 569 | ½Ç³»È¯°æ°ü¸®(Indoor Air Quality Control) | 3 | ||
| HLT 570 | ³ëÃâ ¹× ÀÛ¾÷ȯ°æÆò°¡ ½Ç½À(Practice of Environmental and Occupational Exposure Assessment) | 3 | ||
| HLT 571 | ȯ°æº¸°Ç ³í¹® Æò°¡ ¼¼¹Ì³ª(Seminar on Evaluation of Environmental Health Literature) | 3 | ||
| HLT 572 | ¼öÁú°ü¸®(Water Quality Management) | 3 | ||
| HLT 573 | ȯ°æ »ê¾÷º¸°Ç ¼¼¹Ì³ª I(Seminar I for Environmental and Occupational Health) | 3 | ||
| HLT 574 | ȯ°æ »ê¾÷º¸°Ç ¼¼¹Ì³ª II(Seminar II for Environmental and Occupational Health) | 3 | ||
| HLT 575 | ȯ°æ »ê¾÷º¸°Ç ¼¼¹Ì³ª III(Seminar III for Environmental and Occupational Health) | 3 | ||
| HLT 576 | ÀÓ»ó »ê¾÷ÀÇÇÐ(Clinical Occupational Medicine) | 3 | ||
| HLT 577 | ȯ°æ ¹× »ê¾÷µ¶¼ºÇÐ ½Ç½À(Practice of Environmental and Occupational Toxicology) | 3 | ||
| HLT 578 | »ê¾÷ȯ±â(Industrial Ventilation) | 3 | ||
| HLT 579 | À¯ÀüÇÐ¿Í °øÁߺ¸°Ç(Genetics and Public Health) | 3 | ||
| HLT 580 | ³ëÃâ Æò°¡ ¹× ȯ°æÀ§Çؼº Æò°¡(Exposure Assessment and Environametal Risk Assessment) | 3 | ||
| HLT 581 | À§Çè°ü¸®±â¹ý(RISK MANAGEMENT) | 3 | ||
| HLT 582 | ȯ°æ ¹× »ê¾÷ À§»ýÇÐ(Principles of Industrial Hygiene) | 3 | ||
| HLT 583 | Àΰú°ü°è·Ð°ú °úÇÐÀûÁõ°Å(Casualith Theory and Scientific Evidence) | 3 | ||
| HLT 584 | »ê¾÷º¸°Ç¾ÈÀü°ü¸® ½Ã½ºÅÛ(OHSMS, Occupational Health and Safety Management System) | 3 | ||
| Àü°ø ÀÎÁ¤ °ú¸ñ | HLT 728 | ±¹°¡»ê¾÷º¸°ÇÁ¦µµ ¹× °ü¸®(National Occupational Health Policy and Management) | 3 | |
| HLT 729 | »êÀ纸Çè·Ð(Workers's compensation insurance) | 3 | ||
| HLT 730 | »ê¾÷º¸°Ç¾ÈÀü°ü¸®½Ã½ºÅÛ(OHSMS, Occupational Health and Safety Management System) | 3 | ||
| HLT 731 | À§Çè°ü¸®±â¹ý(RISK MANAGEMENT) | 3 | ||
| HLT 732 | ÀçÇØºÐ¼®±â¹ý(Analytic method applied to occupational health and safety) | 3 | ||
| HLT 733 | Àΰú°ü°è·Ð°ú °úÇÐÀû Áõ°Å(Causality theory and scienrific evidence) | 3 | ||
| HLT 745 | º¸°ÇÇп¡¼ÀÇ Àΰ£°øÇа³·Ð(Ergonomics in Health Science) | 3 | ||
| HLT 747 | º¸°Ç, ¾ÈÀü ¹× ȯ°æ Á¤Ã¥ ¹× °ü¸® ¼¼¹Ì³ª(Seminars on Health, Safety and Environment Management Policy) | 3 | ||
| HLT 748 | °Ç° ¹× ȯ°æÀ§Ç輺 Æò°¡ ¼¼¹Ì³ª(Health and Environmental Risk Assessment) | 3 | ||
| ¿ªÇÐ ¹× ÀÇ·áÁ¤º¸ÇÐ Àü°ø°ú¸ñ | HLT 631 | ÀÇ·áÁ¤º¸ÇÐ(Medical Informatics) | 3 | |
| HLT 632 | ¿ªÇבּ¸¹æ¹ý·Ð(Research Methodology) | 3 | Çʼö | |
| HLT 633 | Áß±Þ Åë°èÇÐ(Intermediate Statistics) | 3 | ||
| HLT 634 | °¨¿°º´¿ªÇÐ(Epidemiology of Infectious Disease) | 3 | ||
| HLT 635 | ÀÓ»ó¿ªÇÐ(Clinical Epidemiology) | 3 | ||
| HLT 636 | ¸¸¼ºº´¿ªÇÐ(Epidemiology of Chronic Disease) | 3 | ||
| HLT 637 | ¿ªÇм¼¹Ì³ª(Seminar in Epidemiology) | 3 | ||
| HLT 638 | ȯ°æ ¹× »ê¾÷¿ªÇÐ(Environmental and Occupational Epidemiology) | 3 | ||
| HLT 639 | ÀÇ·áÁ¤º¸ÇÐ ¼¼¹Ì³ª(Seminar in Medical Informatics) | 3 | ||
| HLT 640 | ÀÓ»óÀÇ·áÁ¤º¸ÇÐ(Clinical Informatics) | 3 | ||
| HLT 641 | º´¿ø°¨¿°°ü¸®(Hospital Epidemiology and Infection Control) | 3 | ||
| HLT 642 | °í±Þ Åë°èÇÐ(Advanced Statistics) | 3 | ||
| HLT 643 | ¿ªÇÐÆ¯·Ð(Topics in Epidemiology) | 3 | ||
| HLT 644 | °í±Þ¿ªÇÐ(Advanced Course in Epidemiology) | 3 | ||
| HLT 646 | ÀÇ·áÁ¤º¸ÇÐÆ¯·Ð(Topics in Medical Informatics) | 3 | ||
| HLT 647 | °øÁߺ¸°ÇÁ¤º¸ÇÐ(Public Health Informatics) | 3 | ||
| HLT 648 | °è·®¿ªÇÐ(Quantitative Epidemiology) | 3 | ||
| HLT 649 | Áý´ÜÀ¯ÀüÇÐ(Genetic Epidemiology of Population) | 3 | ||
| HLT 650 | ÀÇ»ç°áÁ¤¹æ¹ý·Ð(Decision Making Mathodology) | 3 | ||
| HLT 651 | »çȸ¿ªÇÐ(Social Epidemiology) | 3 | ||
| HLT 652 | º¸°ÇÀÇ·á Áö´ÉÁ¤º¸½Ã½ºÅÛ(Intelligent Information System in Healthcare) | 3 | ||
| HLT 653 | ¿©¼º°Ç°(Women Health) | 3 | ||
| HLT 654 | ³ëÀΰǰ(Elderly Health) | 3 | ||
| HLT 655 | º¸°ÇÀÇ·áÁ¤º¸ÇÐ(Health and Medical Informatics) | 3 | ||
| HLT 656 | º¸°ÇÀÇ·áÁ¤º¸ÇÐÆ¯·Ð(Topics in Health and Medical Informatics) | 3 | ||
| HLT 657 | º¸°ÇÀÇ·áÁ¤º¸ÇÐ ¼¼¹Ì³ª(Seminar in Health and Medical Informatics) | 3 | ||
| HLT 658 | ¾Ï ¿ªÇÐ ¹× ¿¹¹æ(Cancer Epidemiology & Prevention) | 3 | ||
| HLT 659 | ȯ°æ¿ªÇÐ(Environmental Epidemiology) | 3 | ||
| HLT 661 | ¿ªÇבּ¸ »ç·ÊºÐ¼®(Critical Review of Epidemiologic Studies) | 3 | ||
| º¸°ÇÁ¤Ã¥ ¹× º´¿ø°ü¸®ÇÐ Àü°ø°ú¸ñ | HLT 701 | º¸°ÇÁ¤Ã¥ ¹× °ü¸®(Health Policy and Management) | 3 | |
| HLT 702 | °Ç°ÁõÁø ¹× º¸°Ç±³À°(Health Promotion and Health Education) | 3 | ||
| HLT 703 | º¸°Ç°æÁ¦ÇÐ(Health Economics) | 3 | ||
| HLT 704 | ÀǷẸÀå·Ð(Social Security for Medical Care) | 3 | ||
| HLT 705 | º¸°Ç°ü¸®ÇÐ ¿¬±¸¹æ¹ý·Ð(Methodology for Health Service Research) | 3 | ||
| HLT 706 | º´¿ø °ü¸®ÇÐ(Hospital Management) | 3 | ||
| HLT 707 | º¸°Ç »çȸÇÐ(Sociology in Health) | 3 | ||
| HLT 708 | º¸°ÇÁ¤Ã¥ ¼¼¹Ì³ª(Seminars in Health Policy and Management) | 3 | ||
| HLT 709 | º¸°ÇÀǷἺñ½º Æò°¡·Ð(Evaualtion of Health Care Services) | 3 | ||
| HLT 710 | ÀÇ·áÀÇ Áú°ü¸® | 3 | ||
| HLT 711 | ÀÇ·á±â°ü °æ¿µ(management of health care organization) | 3 | ||
| HLT 712 | ÀÇ·áÁ¶Á÷°ü¸®·Ð(Management of Hospitals and Healthcare Organizations) | 3 | ||
| HLT 713 | ÀÏÂ÷ÀÇ·á ¹× ÀÇ·áÀü´Þü°è(Primary Care and Health Care Delivery System) | 3 | ||
| HLT 714 | º¸°ÇÀÇ·á±â¼úÆò°¡·Ð(Technology Assessment in Health Care) | 3 | ||
| HLT 715 | ±Ù°ÅÁ߽ɺ¸°ÇÀÇ·á(Evidence-Based Health Care) | 3 | ||
| HLT 716 | Çѱ¹º¸°ÇÁ¤Ã¥·Ð(Health Policy in Korea) | 3 | ||
| HLT 717 | ÀǷẸÇè·Ð(Health Insurance) | 3 | ||
| HLT 718 | º¸°Ç»ç(History of Health) | 3 | ||
| HLT 719 | º¸°ÇÁ¤Ã¥ºÐ¼®·Ð(Health Policy Analysis) | 3 | ||
| HLT 720 | ºñ±³ÀÇ·áÁ¦µµ·Ð(Comparative Study of Health Care System) | 3 | ||
| HLT 721 | º¸°Ç°æÁ¦ÇÐ ¹æ¹ý·Ð(Health Economics Research Methods) | 3 | ||
| HLT 722 | º¸°Ç°ü¸®ÀÇ À±¸®(Ethics of Health Care Policy and Management) | 3 | ||
| HLT 723 | º¸°ÇÁ¤Ã¥ ¼¼¹Ì³ª(Seminar in Health Policy) | 3 | ||
| HLT 724 | º´¿ø°æ¿µ ¼¼¹Ì³ª(Seminar in Hospital Management) | 3 | ||
| HLT 725 | ÀÇ·á±â¼úÆò°¡ ¼¼¹Ì³ª(Seminar in Health Care Technology Assessment) | 3 | ||
| HLT 726 | º¸°Ç°ü¸® ³í¹®Æò°¡ ¼¼¹Ì³ª(Seminar in Assessment of Health Service Research Papers) | 3 | ||
| HLT 727 | º¸°Ç°ü¸® ³í¹®Ãʵ¶ ¼¼¹Ì³ª(Seminar in Reading of Health Service Research Paper) | 3 | ||
| HLT 728 | ±¹°¡»ê¾÷º¸°ÇÁ¦µµ ¹× °ü¸®(National Occupational Health Policy and Management) | 3 | ||
| HLT 729 | »êÀ纸Çè·Ð(Workers's compensation insurance) | 3 | ||
| HLT 730 | »ê¾÷º¸°Ç¾ÈÀü°ü¸®½Ã½ºÅÛ(OHSMS, Occupational Health and Safety Management System) | 3 | ||
| HLT 731 | À§Çè°ü¸®±â¹ý(RISK MANAGEMENT) | 3 | ||
| HLT 732 | ÀçÇØºÐ¼®±â¹ý(Analytic method applied to occupational health and safety) | 3 | ||
| HLT 733 | Àΰú°ü°è·Ð°ú °úÇÐÀû Áõ°Å(Causality theory and scienrific evidence) | 3 | ||
| HLT 734 | ³í¹®Æò°¡ ¼¼¹Ì³ª(Seminar in Assessment of Research Papers) | 3 | ||
| HLT 735 | ÀÇ·á±â°ü °æ¿µ»ç·Ê¿¬±¸(Research of Cases in Hospitals and Healthcare Services Management) | 3 | ||
| HLT 736 | º¸°ÇÁ¤Ã¥¼¼¹Ì³ª II(Seminar in Health Policy II) | 3 | ||
| HLT 737 | ÀÇ·á±â°ü °æ¿µ¼¼¹Ì³ª(Seminar in Healthcare Organizations Management) | 3 | ||
| HLT 738 | º´¿ø°æ¿µ¼¼¹Ì³ª II(Seminar in Hospital Management II) | 3 | ||
| HLT 739 | º´¿øÈ¸°èÇÐ(Hospital Accounting) | 3 | ||
| HLT 740 | ÀÇ·á±â¼úÆò°¡ ¼¼¹Ì³ª II(Seminar in Health Care Technology Assessment II) | 3 | ||
| HLT 741 | º¸°ÇÀÇ·á½Ã¼³°èȹ¹æ¹ý·Ð(Methodology in Healthcare Facility Planning) | 3 | ||
| HLT 742 | º¸°Ç°ü¸® ³í¹®Æò°¡ ¼¼¹Ì³ª II(Seminar in Assessment of Health Service Research Papers II) | 3 | ||
| HLT 751 | ÀÇ·áÀÇ Áú°ü¸®(Quality assurance in health care organization) | 3 | ||
| HLT 752 | ÀÇ·áÀÇ Áú°ü¸® II(Quality assurance in Health Care Organization II) | 3 | ||
| HLT 744 | º¸°Ç°ü¸® ³í¹®Ãʵ¶ ¼¼¹Ì³ª II(Seminar in Health Service Research Paper II) | 3 | ||
| HLT 745 | º¸°ÇÇп¡¼ÀÇ Àΰ£°øÇа³·Ð(Ergonomics in Health Science) | 3 | ||
| HLT 746 | ÀǷἺñ½º¸¶ÄÉÆÃ·Ð(Theory on Marketing of Healthcare Services) | 3 | ||
| HLT 747 | º¸°Ç, ¾ÈÀü ¹× ȯ°æ Á¤Ã¥ ¹× °ü¸® ¼¼¹Ì³ª(Seminars on Health, Safety and Environment Management Policy) | 3 | ||
| HLT 748 | °Ç° ¹× ȯ°æÀ§Ç輺 Æò°¡ ¼¼¹Ì³ª(Health and Environmental Risk Assessment) | 3 | ||
| HLT 750 | °Ç° ÁõÁø ±âȹ·Ð(Health Promotion Planning) | 3 | ||
| HLT 751 | ÀÇ·áÀÇ Áú°ü¸®(Quality assurance in health care organization) | 3 | ||
| HLT 752 | ÀÇ·áÀÇ Áú°ü¸® II(Quality assurance in Health Care Organization II) | 3 | ||
| HLT 753 | Áö¿ª»çȸ º¸°Ç »ç¾÷·Ð (Community health program) | 3 | ||
| HLT 754 | °Ç°ÁõÁø (Health Promotion) | 3 |
ÀÇÇÐÅë°èÇÐ Çùµ¿°úÁ¤ °³¼³°ú¸ñ
| ±¸ºÐ | °ú¸ñÄÚµå | ±³°ú¸ñ¸í | ÇÐÁ¡ | ºñ°í |
|---|---|---|---|---|
| Àü°ø°ú¸ñ | BST 551 | ÀÇÇÐÅë°èÇÐ ÀÌ·Ð 1(Theory of Biostatistics 1) | 3 | ¼®»ç Çʼö |
| BST 552 | ÀÇÇÐÅë°èÇÐ ÀÌ·Ð 2(Theory of Biostatistics 2) | 3 | ¼®»ç Çʼö | |
| BST 553 | ÀÇÇÐÅë°è »ó´ã 1(Biostatistical Consulting 1) | 3 | ¼®»ç Çʼö, ¹Ú»ç Çʼö | |
| BST 554 | ÀÇÇÐÅë°è »ó´ã 2(Biostatistical Consulting 2) | 3 | ||
| BST 555 | ÀÇÇÐÅë°è »ó´ã 3(Biostatistical Consulting 3) | 3 | ||
| BST 556 | ÀÇÇÐÅë°è »ó´ã 4(Biostatistical Consulting 4) | 3 | ||
| BST 652 | ÀÀ¿ë ´Ùº¯·®ÀÚ·á ºÐ¼®(Applied Multivariate Data Analysis) | 3 | ||
| BST 653 | »ýÁ¸ÀÚ·á ºÐ¼®(Survival Data Analysis) | 3 | ¹Ú»ç Çʼö | |
| BST 655 | ÀÓ»ó½ÃÇè ¹æ¹ý·Ð(Biostatistical Methodologies in Clinical Trials) | 3 | ||
| BST 656 | ÀÇÇÐÅë°è ȸ±ÍºÐ¼®(Regression Analysis in Biostatistics) | 3 | ||
| BST 657 | ½ÇÇè¼³°è ¹× ºÐ¼®(Biostatistical Design and Analysis) | 3 | ||
| BST 659 | ÀÇÇÐÅë°è Ç¥º»·Ð(Survey Methodology in Biostatistics) | 3 | ||
| BST 731 | ¿ªÇÐ(Epidemiology) | 3 | ¼®»ç Çʼö | |
| BST 821 | ÀÇÇÐÅë°èÇРƯ° 1(Special Topics in Biostatistics 1) | 3 | ||
| BST 822 | ÀÇÇÐÅë°èÇРƯ° 2(Special Topics in Biostatistics 2) | 3 | ||
| BST 831 | ÀÇÇÐÅë°èÇÐ ¼¼¹Ì³ª 1(Seminar in Biostatistics 1) | 3 | ||
| BST 832 | ÀÇÇÐÅë°èÇÐ ¼¼¹Ì³ª 2(Seminar in Biostatistics 2) | 3 | ||
| BST 841 | ÀÇÇÐÅë°èÇÐ ³í¹®¼¼¹Ì³ª 1(Dissertation Seminar 1) | 3 | ||
| BST 842 | ÀÇÇÐÅë°èÇÐ ³í¹®¼¼¹Ì³ª 2(Dissertation Seminar 2) | 3 | ||
| BST 843 | ÀÇÇÐÅë°èÇÐ ³í¹®¼¼¹Ì³ª 3(Dissertation Seminar 3) | 3 | ||
| BST 844 | ¹üÁÖÇü ÀÚ·áÀÇ ºÐ¼®(Categorical Data Analysis) | 3 | ||
| BST 845 | ¹Ýº¹ÃøÁ¤ ÀÚ·áÀÇ ºÐ¼®(Analysis of Repeated Measures Data) | 3 | ¹Ú»ç Çʼö | |
| BST 846 | ÀϹݼ±Çü¸ðÇü·Ð(General Linear Models) | 3 | ||
| BST 847 | ÀÇÇÐÅë°èÇÐ °í±Þ ÀÌ·Ð(Advanced Theory in Biostatistics) | 3 | ||
| BST 848 | ÀÇÇÐÅë°èÇÐ °è»ê ÀÌ·Ð(Computational Biostatistics) | 3 | ¹Ú»ç Çʼö | |
| BST 850 | º£ÀÌÁö¾È ¹æ¹ý·Ð(Bayesian Theory) | 3 | ||
| BST 852 | ¿ªÇבּ¸ÀÇ Åë°èÀû ¹æ¹ý·Ð(Biostatistical Methods in Epidemiologic Study) | 3 | ||
| BST 853 | ü°èÀû °íÂû ¹× ¸ÞŸºÐ¼®(Systematic Review and Meta Analysis) | 3 | ||
| BST 854 | °áÃø ¹× ºÒ¿ÏÀü ÀÚ·áºÐ¼®(Analysis of Incomplete Data) | 3 | ||
| BST 855 | Åë°èÀû ÀΰúÃß·Ð ¹æ¹ý·Ð(Statistics of Causal Inference) | 3 |
ÀǰúÇаú °³¼³°ú¸ñ
| ±¸ºÐ | °ú¸ñÄÚµå | ±³°ú¸ñ¸í | ÇÐÁ¡ | |
|---|---|---|---|---|
| ±âÃʰøÅë°ú¸ñ | BMS 501 | ÀǰúÇÐ ÀÎü»ý¸®ÇÐ(BM Human Physiology) | 3 | |
| BMS 503 | ÀǰúÇÐ ºÐÀÚ¼¼Æ÷»ý¹°ÇÐ(BM Molecular and Cell Biology) | 3 | ||
| BMS 504 | ÀǰúÇÐ ÀÓ»óÀÇÇÐ °³·Ð(BM Introduction to the Clinical Medicine) | 3 | ||
| BMS 505 | ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª I(BM Biomedical Seminars I) | 3 | ||
| BMS 506 | ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª II(BM Biomedical Seminars II) | 3 | ||
| BMS 507 | ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª III(BM Biomedical Seminars III) | 3 | ||
| BMS 508 | ÀǰúÇÐ ÃÖ½ÅÀÇÇм¼¹Ì³ª(BM Biomedical Seminars IV) | 3 | ||
| BMS 509 | ÀǰúÇÐ ¿¬±¸ÀÇ ±âÃÊ (BM Foundation of Biomedical Research) | 3 | ||
| BMS 510 | ÀǰúÇÐ °í±ÞºÐÀÚ¼¼Æ÷»ý¹°ÇÐ(BM Advanced Molecular and Cell Biology) | 3 | ||
| BMS 511 | ÀǰúÇÐ ÀÇ¿ë»ýü°øÇа³·Ð (BM Introduction to Biomedical Engineering) | 3 | ||
| BMS 527 | ÀǰúÇÐ ÀÎÃ¼ÇØºÎÇÐ(BM Human Anatomy) | 3 | ||
| ÀϹݼ±Åðú¸ñ | BMS 512 | ÀǰúÇÐ ¿¬±¸½ÇÇè±â¹ý(BM Laboratory Methods) | 3 | |
| BMS 513 | ÀǰúÇÐ ¹Ì»ý¹°ÇÐ ¹× ¸é¿ªÇÐ(BM Microbiology and Immunology) | 3 | ||
| BMS 514 | ÀǰúÇÐ ÀÇ»ý¸í °úÇÐÁ¤º¸(BM Biomedical Infomatics) | 3 | ||
| BMS 515 | ÀǰúÇÐ ±âÃʺ´¸®ÇÐ °³·Ð(BM Basic Pathology) | 3 | ||
| BMS 516 | ÀǰúÇÐ °í±Þ¸é¿ªÇÐ(BM Advanced Immunology) | 3 | ||
| BMS 517 | ÀǰúÇÐ ÀÇ»ý¹°ÇÐ ¿¬±¸ ¹æ¹ý·Ð(BM Research Methodology for Biomedical Science) | 3 | ||
| BMS 518 | ÀǰúÇÐ ¹ß»ýÇа³·Ð (BM Principles of Developmental Biology) | 3 | ||
| BMS 519 | ÀǰúÇÐ ÃֽŠÀÇ»ý¸í°úÇÐ (BM Emerging medical biology) | 3 | ||
| BMS 520 | ÀǰúÇÐ º´Å»ý¸®¿Í ¾à¸®ÇÐ (BM Pathophysiology and Pharmacology) | 3 | ||
| BMS 521 | ÀǰúÇÐ ¹ÙÀÌ·¯½ºÇÐ ¿ø·Ð (BM Principles of Virology) | 3 | ||
| BMS 522 | ÀǰúÇÐ ½Å¾à°³¹ßƯ·Ð (BM Advanced drug discovery and development) | 3 | ||
| BMS 523 | ÀǰúÇÐ Á¦Á¦ÇÐÆ¯·Ð (BM Advanced Pharmaceutics) | 3 | ||
| BMS 524 | ÀǰúÇÐ ³í¹®¹ßÇ¥¼¼¹Ì³ª (BM Wo°¡-In Progress Seminar) | 3 | ||
| BMS 525 | ÀǰúÇÐ »ýÈÇРƯ·Ð I (BM Advanced Biochemistry I) | 3 | ||
| BMS 526 | ÀǰúÇÐ »ýÈÇРƯ·Ð II (BM Advanced Biochemistry II) | 3 | ||
| Àü°ø°ú¸ñ | ½Å°æ»ý¹°ÇÐ Àü°ø | BMS 601 | ÀǰúÇÐ ½Å°æ»ý¸®ÇÐ(BM Neurophysiology) | 3 |
| BMS 602 | ÀǰúÇÐ ½Å°æ¾à¸®ÇÐ(BM Neuropharmacology) | 3 | ||
| BMS 603 | ÀǰúÇÐ ÀÚÀ²½Å°æ°è(BM Autonomic Nervous System) | 3 | ||
| BMS 604 | ÀǰúÇÐ ºÐÀÚ¼¼Æ÷½Å°æ»ý¹°ÇÐ(BM Molecular Neurobiology) | 3 | ||
| BMS 605 | ÀǰúÇÐ ½Å°æ³»ºÐºñÇÐ(BM Neuroendocrinology) | 3 | ||
| BMS 606 | ÀǰúÇÐ ½Å°æ°èÁúȯ(BM Diseases in the nervous system) | 3 | ||
| BMS 607 | ÀǰúÇÐ ½Å°æÁ¤½Å¾à¸®ÇÐ (BM Neuropsychopharmacology) | 3 | ||
| BMS 608 | ÀǰúÇÐ ³ëÈÀÇ À¯ÀüÇÐ ¸ðµ¨ (BM Genetic Models in Aging) | 3 | ||
| BMS 609 | ÀǰúÇÐ Áúº´°ú ÃÊÆÄ¸® À¯ÀüÇÐ (BM Drosophila Genetics in Human Diseases) | 3 | ||
| BMS 610 | ÀǰúÇÐ ½Å°æ°úÇÐ ÁÖÁ¦¿¬±¸ (BM Topics in Neuroscience) | 3 | ||
| BMS 611 | ÀǰúÇÐ ½Å°æ°úÇÐ ¼¼¹Ì³ª (BM Seminars in Neuroscience) | 3 | ||
| BMS 612 | ÀǰúÇÐ ½Å°æ°úÇÐÀÇ ¿ø¸® (BM Principles of Neural Science) | 3 | ||
| ºÐÀÚ ÀÎü À¯ÀüÇÐ Àü°ø | BMS 613 | ÀǰúÇÐ À¯ÀüÀÚÄ¡·áÇÐ °³·Ð(BM Concepts of Cancer Gene Therapy) | 3 | |
| BMS 614 | ÀǰúÇÐ »ý¸í°øÇÐÀ±¸®(BM Ethics of Medical Biotechnology) | 3 | ||
| BMS 615 | ÀǰúÇÐ °í±Þ ½Å°æ»ý¹°ÇÐ I(BM Advanced Neurobiology I) | 3 | ||
| BMS 616 | ÀǰúÇÐ °í±Þ ½Å°æ»ý¹°ÇÐ II(BM Advanced Neurobiology II) | 3 | ||
| BMS 617 | ÀǰúÇÐ ¹ß´Þ À¯ÀüÇÐ I(BM Developmental Genetics I) | 3 | ||
| BMS 618 | ÀǰúÇÐ ¹ß´Þ À¯ÀüÇÐ II(BM Developmental Genetics II) | 3 | ||
| BMS 619 | ÀǰúÇÐ ¼¼Æ÷¸· ¼ö¿ëü¿Í ½ÅÈ£Àü´Þ(BM Membrane receptors and signal transduction) | 3 | ||
| BMS 620 | ÀǰúÇÐ ºÐÀÚ ½Å°æ³»ºÐºñÇÐ(BM Molecular Neuroendocrinology) | 3 | ||
| BMS 621 | ÀǰúÇÐ Áٱ⼼Æ÷·Ð(BM Stem Cell Biology) | 3 | ||
| BMS 622 | ÀǰúÇÐ ºÐÀÚ ¹ß»ý»ý¹°ÇÐ(BM Molecular Developmental Biology) | 3 | ||
| BMS 623 | ÀǰúÇÐ Àü»çÀÎÀÚ (BM transcription factors) | 3 | ||
| BMS 624 | ÀǰúÇÐ ½ÅÈ£Àü´Þ ºÐÀÚ ³×Æ®¿öÅ© (BM Molecular networks in signal transduction) | 3 | ||
| ÀÇ¿ë»ýü°øÇÐ Àü°ø | BMS 625 | ÀǰúÇÐ Àǰø ÇǺΰúÇÐ(BM Dermatology for Bioengineering) | 3 | |
| BMS 626 | ÀǰúÇÐ »ýü Ç¥¸éÇÐ(BM Biomedical Metrology) | 3 | ||
| BMS 627 | ÀǰúÇÐ ÀÇ»ý¸í Çö¹Ì°æÇÐ(BM Biomedical Microscopy) | 3 | ||
| BMS 628 | ÀǰúÇÐ °í±Þ ¿µ»ó ºÐ¼®ÇÐ(BM Advanced Image Analysis) | 3 | ||
| BMS 629 | ÀǰúÇÐ ¿µ»ó ºÐ¼®ÇÐ ±âÃÊ(BM Basic Image Analysis) | 3 | ||
| BMS 630 | ÀǰúÇÐ ¾à¹°Àü´Þü°è(BM Drug Delivery System) | 3 | ||
| BMS 631 | ÀǰúÇÐ ÀǰøÇÐ ÁÖÁ¦¿¬±¸ I(BM Topics in Biomedical Engineering I) | 3 | ||
| BMS 632 | ÀǰúÇÐ ÀǰøÇÐ ÁÖÁ¦¿¬±¸ II(BM Topics in Biomedical Engineering II) | 3 | ||
| BMS 633 | ÀǰúÇÐ ÀΰøÀå±âÇÐ(BM Artificial Organs) | 3 | ||
| BMS 634 | ÀǰúÇÐ °íºÐÀÚ »ýüÀç·áÇÐ(BM Polymers in Biomaterials) | 3 | ||
| BMS 635 | ÀǰúÇÐ Á¶Á÷ ¹× ¼¼Æ÷°øÇÐ(BM Tissue and Cellular Engineering) | 3 | ||
| BMS 636 | ÀǰúÇÐ »ýüÀç·á¿Í »ýüÀûÇÕ¼º(BM Biomaterials and Biocompatibility) | 3 | ||
| BMS 637 | ÀǰúÇÐ ³ª³ë »ýüÀç·á(BM Nano-biomaterials) | 3 | ||
| BMS 638 | ÀǰúÇÐ ³ª³ë ÀÇ·á±â¼ú Ư·Ð(BM Topics on Nano-medical Technology) | 3 | ||
| BMS 639 | ÀǰúÇÐ ÀÇÇй°¸®(BM Medical Physics) | 3 | ||
| BMS 640 | ÀǰúÇÐ Àΰø½ÉÀå Æ¯°(BM Artificial Heart) | 3 | ||
| BMS 641 | ÀǰúÇÐ ºñħ½ÀÀǰøÇÐ(BM non-invasive bioengineering) | 3 | ||
| BMS 642 | ÀǰúÇÐ ÈÇпµ»ó Áø´ÜÇÐ(BM chemical imaging for medical diagnosis) | 3 | ||
| BMS 643 | ÀǰúÇÐ ÀÇ·á±â±âÇÐ(BM Technology for the Medical Device) | 3 | ||
| BMS 644 | ÀǰúÇÐ ¹ÙÀÌ¿À Ĩ °³·Ð(BM Introduction of Biochip) | 3 | ||
| BMS 645 | ÀǰúÇÐ ºÐÀÚ»ý¹° ÀüÀÚÆ¯·Ð(BM Biology for Engineers) | 3 | ||
| °¨¿°¡¤¸é¿ªÇÐ Àü°ø | BMS 646 | ÀǰúÇÐ °í±ÞºÐÀڹ̻ý¹°ÇÐ(BM Advanced Molecular Microbiology) | 3 | |
| BMS 647 | ÀǰúÇÐ ºÐÀÚ¼¼±ÕÇÐ(BM Molecular Bacteriology) | 3 | ||
| BMS 648 | ÀǰúÇÐ ÃֽŠÀÇÇйÙÀÌ·¯½ºÇÐ(BM Emerging Medical Virology) | 3 | ||
| BMS 649 | ÀǰúÇÐ °í±Þ ¸é¿ªÇÐ I(BM Advanced Immunology I) | 3 | ||
| BMS 650 | ÀǰúÇÐ °í±Þ ¸é¿ªÇÐ II(BM Advanced Immunology II) | 3 | ||
| BMS 651 | ÀǰúÇÐ Á¾¾ç¹ÙÀÌ·¯½ºÇÐ(BM Oncogenic Virology) | 3 | ||
| BMS 652 | ÀǰúÇÐ ¸é¿ªÁúȯ ¿¬±¸(BM Research of Immune related disease) | 3 | ||
| BMS 653 | ÀǰúÇÐ °¨¿°Áõ¿¡ ´ëÇÑ ¼±Ãµ¸é¿ª(BM Innate Immune Response to Infection) | 3 | ||
| BMS 654 | ÀǰúÇÐ À¯ÀüÀÚ¹é½ÅÀÇ Àü·«(BM Strategies of Genetic Vaccine) | 3 | ||
| BMS 655 | ÀǰúÇÐ ÀÏ¹Ý ¸é¿ªÇÐ ¥° (BM General Immunology) | 3 | ||
| BMS 656 | ÀǰúÇÐ ÀÏ¹Ý ¸é¿ªÇÐ ¥±(BM General Immunology) | 3 | ||
| BMS 657 | ÀǰúÇÐ ½Ã½ºÅÛ»ý¹°ÇÐ (BM Systems Biology) | 3 | ||
| Á¾¾ç»ý¹°ÇÐ Àü°ø | BMS 658 | ÀǰúÇÐ Á¾¾ç ºÐÀÚ»ý¹°ÇÐ(BM Oncogene Molecular Biology) | 3 | |
| BMS 659 | ÀǰúÇÐ ¾Ï¹ß»ýÇÐ(BM Carcinogenesis) | 3 | ||
| BMS 660 | ÀǰúÇÐ ¾ÏÄ¡·áÇÐ(BM Cancer Treatment) | 3 | ||
| BMS 661 | ÀǰúÇÐ ¾Ï¿¹¹æÇÐ(BM Cancer Prevention) | 3 | ||
| BMS 662 | ÀǰúÇÐ ¼Òȱâ Á¾¾çÇÐ(BM Gastrointestinal Oncology) | 3 | ||
| BMS 663 | ÀǰúÇРȣÈí±â Á¾¾çÇÐ(BM Pulmonary Oncology) | 3 | ||
| BMS 664 | ÀǰúÇÐ ºÐÀÚ»ý¹°ÇРƯ·Ð(BM Advanced Molecular Biology) | 3 | ||
| BMS 665 | ÀǰúÇÐ Á¾¾ç ¸é¿ªÇÐ(BM Tumor Immunology) | 3 | ||
| BMS 666 | ÀǰúÇÐ ¾Ï ¿ªÇÐ ¹× ¿¹¹æ(BM Cancer Epidemiology & Prevention) | 3 | ||
| BMS 667 | ÀǰúÇÐ ÃֽоÏÀ¯ÀüÀÚÇÐ(BM Emerging Molecular Oncology) | 3 | ||
| BMS 668 | ÀǰúÇÐ Ç׾ϳ»¼º (BM Resistance of Tumor Cells to Therapeutics) | 3 | ||
| BMS 669 | ÀǰúÇÐ Á¾¾çÁٱ⼼Æ÷»ý¹°ÇÐ (BM Cancer Stem Cell Biology) | 3 | ||
| BMS 670 | ÀǰúÇÐ Á¾¾ç ºÐÀÚ»ý¹°ÇÐ ¿¬±¸ ±â¹ý (BM Principles and techniques of molecular biology of cancer) | 3 | ||
| BMS 671 | ÀǰúÇÐ Ç׾ϺÐÀÚÄ¡·á (BM Anti-tumor Molecular Therapy) | 3 | ||
| BMS 672 | ÀǰúÇÐ ¾ÏÀüÀÌÀÇ ÀÌÇØ (BM Understanding of Metastasis) | 3 | ||
| BMS 673 | ÀǰúÇÐ ¾Ï »ý¹°ÇÐ ÁÖÁ¦¿¬±¸ (BM Topics in Cancer Biology) | 3 | ||
| BMS 674 | ÀǰúÇÐ ¾Ï »ý¹°ÇÐ ¼¼¹Ì³ª (BM Seminars in Cancer Biology) | 3 | ||
| ºÐÀÚ¼¼Æ÷¹ß»ý»ý¹°ÇÐ Àü°ø | BMS 675 | ÀǰúÇÐ ¼¼Æ÷ÈÇÐ(BM Cytochemistry) | 3 | |
| BMS 676 | ÀǰúÇÐ ¹Ì¼¼Á¶Á÷»ý¹°ÇÐ(BM Ultrastructural Biology of Cell and Tissue) | 3 | ||
| BMS 677 | ÀǰúÇÐ À¯ÀüÀÚÀÇ ¹ßÇö Á¶Àý(BM Regulation of Gene Expression) | 3 | ||
| BMS 678 | ÀǰúÇÐ ³ëÈÀÇ »ý¹°ÇÐ(BM Biology of Aging) | 3 | ||
| BMS 679 | ÀǰúÇÐ °í±ÞÀÎü»ýÈÇÐ(BM Advanced Human Biochemistry) | 3 | ||
| BMS 680 | ÀǰúÇÐ ¼¼Æ÷ÁÖ±âÁ¶Àý ¹× ¼¼Æ÷»ç¸ê(BM Cell Cycle and Apoptosis) | 3 | ||
| BMS 681 | ÀǰúÇÐ »ý¸í°øÇÐ(BM Biotechnology) | 3 | ||
| BMS 683 | ÀǰúÇÐ Àΰ£ÁúȯÀÇ ±¸Á¶ÇÐÀû Á¢±Ù(BM Structural Basis of Human Diseases) | 3 | ||
| BMS 684 | ÀǰúÇÐ ½Å°æ¹ß»ýÀ¯ÀüÇÐ (BM Neurodevelopmental genetics) | 3 | ||
| BMS 685 | ÀǰúÇÐ °í±Þ¹ß»ý»ý¹°ÇÐ I (BM Advanced Developmental Biology I) | 3 | ||
| BMS 686 | ÀǰúÇÐ °í±Þ¹ß»ý»ý¹°ÇÐ II (BM Advanced Developmental Biology II) | 3 | ||
| BMS 687 | ÀǰúÇÐ Á¤º¸Àü´Þ°è(BM Signal Transduction) | 3 | ||























